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Abstract –  
Consuming low-fat milk (LFM) after resistance training leads to improvements in body 
composition. Habitual aerobic exercise and dairy intake are relatively easy lifestyle 
modifications that could benefit a population at risk for becoming obese. Thus, the 
purpose of this study was to investigate combining increased LFM intake with endurance 
exercise on body composition, blood-lipid profile and metabolic markers. 40 young males 
were randomized into four groups: one ingesting 750mL LFM immediately post-exercise, 
the other 6hrs post-exercise; and two isocaloric carbohydrate groups ingesting at the two 
different times. Participants completed a 12 week endurance-training program (cycling 1 
hour/day at ~60%VO2peak, 5 days/week). 23 participants completed the study. Increases 
in lean mass (p < 0.05), and decreases in anti-inflammatory marker adiponectin (p < 0.05) 
were seen in all groups. No other significant changes were observed. Future analyses 
should focus on longer duration exercise and include a larger sample.  
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1. Introduction 
1.1 Background – What is obesity?  
Obesity is an excessive or abnormal accumulation and distribution of white 
adipose tissue (WAT) that has been well established as being a major risk factor for 
various chronic disease states [1-4]. The World Health Organization (WHO) uses the 
Body-Mass Index (BMI = weight [kg]/ height [m]
2
) as a simple method of classifying 
individuals as being normal weight, overweight or obese [5]. Using this method, 
individuals with a BMI of 30 or greater are classified as ‘obese’. Those who are classified 
as being ‘overweight’, with a BMI of 25-29.9, are at a significantly increased risk of 
becoming obese [5], and are considered as having an increased risk of developing chronic 
diseases. The proportion of the world’s population that is classified as overweight or 
obese is increasing [4, 6-9] due to a number of different factors, including but not limited 
to: reduced physical activity and increased intake of food, specifically consumption of 
energy dense foods [3, 10]. In 2009, approximately two thirds of the adult population of 
the United States was considered overweight or obese [11], while approximately half of 
Canadian adults were considered overweight or obese [8]. Attempts have been made to 
prevent or reverse the growing obesity ‘epidemic’ through different strategies, such as 
reducing the amount of food consumed or focusing on intake of specific foods [11-22], 
and through increasing physical activity in the form of endurance exercise [17, 23-26]. 
Diet and physical activity are very important to overall health. They also appear to have 
important roles in influencing levels of inflammation, one of the chronic problems 
associated with being overweight and obese [2, 7, 10, 17, 19, 26-37]. Chronic 
inflammation is linked to many other health problems associated with increased body 
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mass and decreased physical activity [7, 11, 29, 34, 35, 37, 38]. Considering the 
widespread issues related to excess weight gain and the associated health problems, it is 
important to understand the risks and the various interventions available to counteract or 
even prevent this issue. 
 
2. Review of Literature 
2.1 Increased body mass  
White adipose tissue (WAT) is the major source of stored energy in the human 
body [35]. Any energy-providing macronutrient consumed in excess by the body, 
whether protein, fat or carbohydrate, can be metabolized or stored in WAT as energy 
dense triacylglycerols [3, 35]. More than just being a site for energy storage, WAT is now 
also recognized as having the properties of an endocrine organ [2, 17, 29, 35], with 
visceral adipose tissue deposits being extremely active in this way [3, 9, 11, 17, 26]. 
Leptin and adiponectin are two examples of hormones released from WAT, along with 
numerous other signalling factors [35, 39]. These adipose hormones, collectively called 
adipokines, are suggested to have various influential effects, including: regulation of 
appetite, energy balance, insulin sensitivity, lipid metabolism, and whole body 
inflammation [4, 29, 35]. The various health problems associated with being overweight 
and obese, include: loss of insulin sensitivity (high blood-glucose levels at rest), 
dyslipidemia, hypertension, cardiovascular disease, and some types of cancer [1, 6, 7, 11, 
29, 35, 36, 38, 40]. Based on these observations, the focus of much research has been on 
the links between adipokines and these various disorders [35, 40]. Adipokines have also 
been linked to the formation of ectopic fat accumulation [4, 9]. Ectopic fat is an unusual 
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deposit of triacylglyerols that forms in an area of the body other than adipose tissue, such 
as skeletal muscle or the liver, and is typically associated with development of insulin 
insensitivity [4, 9, 39].  Interestingly, a mechanism that has been identified as a common 
element among these various metabolic problems is inflammation [1, 7, 11, 29, 35, 36, 
38, 41]. 
 
2.2 Inflammation  
Inflammation can be loosely defined as a localized phenomenon which develops 
due to tissue damage and is an important mechanism in the restoration of the damaged 
tissues [42].  However, obesity is associated with what appears to be a state of chronic 
whole body inflammation, that appears to be related to inflammation of WAT deposits [1, 
2, 19, 26, 29, 35, 37, 41]. WAT itself is the source of many components of the typical 
inflammatory response, and some of the factors secreted into the circulation by WAT 
influence other tissues to secrete pro-inflammatory factors [29, 31, 35]. Many markers of 
inflammation, such as the pro-inflammatory cytokines interleukin-6 (IL-6), tumor-
necrosis factor alpha (TNF-α), and C-reactive protein (CRP), are found in unusually high 
levels in the blood of overweight and obese individuals [6, 7, 29, 35, 41]. Increased levels 
of these markers are commonly observed even in young overweight/obese children [33].  
TNF-α is a pro-inflammatory cytokine that is both expressed in and released by 
WAT [35, 39], although it is primarily secreted by macrophages [29]. It appears to play a 
direct role in the development of insulin-resistance through inhibition of insulin signaling 
[2, 29, 35]. Elevated TNF-α levels have also been noted in individuals with inflammatory 
liver disease, and the increased TNF-α levels in this case are seen in conjunction with 
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elevated leptin levels [43]. TNF-α has been suggested to have a key role in the production 
of other cytokines, including IL-6 [29, 35], but the mechanisms underlying this influence 
are unclear. IL-6 not only affects WAT, but is also released into the circulation and acts 
on the liver, increasing the amount of hepatic CRP release [29], which in turn has a role 
in the onset of lipid peroxidation [44]. IL-6 has also been shown to reduce the insulin-
stimulated uptake of glucose by skeletal muscle, thereby contributing to insulin resistance 
[45]. Adiponectin, previously mentioned as one of the influential adipokines, appears to 
have anti-inflammatory and antioxidant properties through inhibition of TNF-α. 
However, as opposed to other adipose-related secretions, adiponectin levels appear to be 
lower in overweight and obese individuals [7, 35, 39, 46].  
It is currently unclear what directly causes this state of chronic inflammation with 
obesity, although a number of possible mechanisms have been suggested. One such 
mechanism is that as WAT accumulates, some of the tissue within these deposits become 
hypoxic due to the reduced vasculature found in adipose tissue [35]. In response to 
localized hypoxia, these areas undergo an acute inflammatory response in an attempt to 
increase blood flow [35]. In brief, this process involves hypoxic inducible factor 1 (HIF-
1), which becomes active under hypoxic conditions and when active, it appears to 
stimulate angiogenesis [47]. Another function of HIF-1 with hypoxia, is the pre-
programmed cell death (apoptosis) of some adipocytes, which would further contributes 
to the increased inflammatory response [3, 46, 47]. As macrophages move into the area to 
dispose of the dead cells, they themselves give off inflammatory cytokines [3, 29, 46]. 
Another suggested mechanism as to why an increase in inflammation is seen with obesity 
may be related to exorbitant macronutrient intake, particularly of fat, which may be 
5 
 
causing inflammatory responses by being mistaken for an external threat [3, 32, 41]. This 
could be due to increased expression of immune receptors, which in turn increase the 
inflammatory response [32, 41].  
Interestingly, other researchers have suggested that chronic inflammation causes 
obesity, rather than being an effect of weight gain [10, 31, 35, 48]. Some studies found 
that the presence of fibrinogen and other inflammatory markers, including CRP and TNF-
α, can predict increased weight gain over a 3-year period [10, 31]. Another study 
suggested that increased levels of inflammatory markers begins in the womb, and it is this 
early exposure that can lead to obesity during childhood and adulthood [48]. Despite the 
lack of clarity on the sequence of events, once adiposity increases and elevated 
inflammatory markers are present within an individual, these factors appear to perpetuate 
one another and in this way are likely ‘causal’ of each other [28, 31, 33]. It is becoming 
apparent that the constant state of inflammation in turn contributes to the pathogenesis of 
many of the other health problems associated with being overweight or obese, including 
insulin resistance, atherosclerosis, oxidative stress and metabolic syndrome [19, 35, 49].  
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Figure 1. Proposed role of adipokine action within overweight/obese individuals, 
illustrated by the solid lines. The dashed lines indicate otherwise healthy functions that 
are inhibited in obesity. Adapted from Bastard et al. [29]. 
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2.3 Interventions 
Two key interventions that are commonly used to combat the increased incidence 
of individuals who are overweight or obese are dietary alterations and/or increased 
physical activity (exercise). Generally these interventions target individuals who are 
overweight or obese in order to induce weight loss through alterations in energy balance 
[8, 17, 24, 50, 51].  Other studies have used the same interventions in an attempt to 
indirectly treat some of the health effects of being overweight or obese, such as reducing 
inflammation and oxidative stress, and improving body composition [8, 17, 23, 24, 26, 
44]. This review will focus specifically on dairy foods and endurance exercise and the 
possible role of these interventions in contributing to overall improvements in the health 
of individuals who are overweight and/or obese. Based on previous literature focusing on 
dietary changes (see Table 1) we see that the ingestion of additional dairy and calcium 
over a period of more than 12 weeks appears to induce benefits such as improved body 
composition with lower fat mass and increased lean mass, increased lipid excretion and 
thereby less lipid deposition, and reduced levels of cholesterol and pro-inflammatory 
markers. Similarly, studies that investigate the effects of exercise (see Table 2) indicate 
that long- and short-term exercise programs can have beneficial effects on body 
composition by lowering body weight and fat mass, reducing unhealthy cholesterol, 
reducing pro-inflammatory markers, and improving levels of glucose and insulin in the 
bloodstream.   
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Table 1. Summary of studies with dietary measures for weight change and/or health risk 
Study Subjects 
 
Intervention Results 
Fecal Fat Excretion 
Bendsen et al. 
[52] 
Overweight ♀♂ 
25-47 yrs 
N = 11 
2 diets, short-term: 
a) High Ca
2+
  
b) Low Ca
2+
  
More fat excretion after a) 
than b) 
Ditscheid et 
al. [53] 
Normal weight 
♀♂ 
25 ± 2 yrs 
N = 31 
2 diets, short-term: 
a) Ca
2+
 phosphate enriched bread  
b) placebo bread  
No difference in excretion 
between groups 
Jacobsen et 
al. [54] 
Overweight ♀♂ 
24 ± 2 yrs 
N = 10 
3 isocaloric diets, short term: 
a) Low Ca
2+
, normal protein  
b) High Ca
2+
, normal protein  
c) High Ca
2+
, high protein  
All groups experienced 
increased fat excretion 
compared to baseline 
 
Lorenzen et 
al. [55] 
Overweight ♂ 
32.8 ± 1.2 yrs 
N = 15 
4 diets, short-term: 
a ) Low Ca
2+
, high fat 
b) High Ca
2+
, high fat 
c) High Ca
2+
, low fat 
d) Low Ca
2+
, low fat 
More fat excretion after 
the high Ca
2+
  diets (b and 
c) than the low Ca
2+
  diets 
(a and d) 
Body Composition 
Caron-Jobin 
et al. [13] 
Overweight ♀  
47 ± 4 yrs 
N/A, cross sectional study ≥2 portions dairy/d 
correlated with smaller 
adipocyte size 
Harvey-
Berino et al. 
[56] 
Overweight and 
obese ♀♂ 
45 ± 6.6 yrs 
N = 54 
Long-term, , moderate exercise, 2 diets 
with calorie deficit: 
a) 3-4 servings dairy /d 
b) 1 serving dairy/d 
All groups lost BW and 
FM post-intervention 
No significant differences 
between groups 
Jacobsen et 
al. [54] 
Overweight ♀♂ 
24.2 ± 2 yrs 
N = 10 
3 isocaloric diets, short-term: 
a) Low Ca
2+
, normal protein  
b) High Ca
2+
, normal protein  
c) High Ca
2+
, high protein  
No BW change in any 
group 
 
Thompson et 
al. [57] 
Obese ♀♂ 
41 yrs 
N = 72 
Long term, 3 diets with calorie deficit: 
a) 2 servings dairy 
b) 4 servings dairy  
c) same as b) with increased fiber 
No significant difference 
in FM or waist + hip 
circumference between 
groups 
Zemel et al. 
[58] 
Obese ♀♂ 
49 ± 6 years 
N = 32 
3 diets with calorie deficit, long-term: 
a) low Ca
2+
 as supplement 
b) high Ca
2+
 as supplement 
c) high Ca
2+
 from dairy 
Group c) had greatest 
decrease in BW 
Zemel et al. 
[59] 
Obese ♀♂ 
41.7 ± 2.7 yrs 
N = 39 
2 phases, long-term:  
1: 2 eucaloric diets –  
a) Low dairy 
b) High dairy 
2: as 1) but 500kcal/d deficit 
Phase 1: no significant 
differences in BM; 
b) lost more trunk fat and 
gained more LM than a) 
Phase 2: b) lost more BM 
and trunk fat, and  gained 
more LM compared to a) 
Zemel et al. 
[37] 
Overweight and 
obese ♀♂ 
31.0 ± 10.3 yrs 
N = 20 
2 diets, randomized crossover: 
a) soy-based placebo 
b) 3 servings dairy/d  
No significant changes in 
BM, FM, Trunk fat, LM 
Blood lipids 
Ditscheid et 
al. [53] 
Normal weight 
♀♂ 
25 ± 2 yrs 
2 diets, short-term: 
a) Ca
2+
 phosphate enriched bread  
b) placebo bread  
TCHOL and LDL lowered 
after CaP diet 
No change after placebo 
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N = 31  
Steinmetz et 
al. [60] 
Normal weight 
and overweight ♂ 
20-36 yrs 
N = 8 
2 diets, short-term: 
a) skim milk 
b) whole milk 
Lower [TCHOL] 
decreased by more after 
skim than whole milk  
Inflammatory Markers 
Zemel et al. 
[37] 
Overweight and 
obese ♀♂ 
31.0 ± 10.3 yrs 
N = 20 
 
2 diets, randomized crossover: 
a) soy-based placebo 
b) 3 servings dairy/d 
Dairy group had 
significant decreases in  
IL-6 and TNF-α  
No changes in soy group 
Abbreviations: ♀ - females; ♂ - males; yrs – years; short-term: less than 12 weeks 
duration; long-term: 12 weeks duration or more; Ca
2+ 
 - calcium; DW – dry weight;  x /d 
–per day;  mo. – month; kcal – kilocalories; BW – body weight; FM – fat mass; LM – 
lean mass; TCHOL - total cholesterol; LDL – low-density-lipoprotein cholesterol; [x] – 
concentration of ‘x’; CD – control diet 
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Table 2. Summary of studies with exercise measures for weight change and/or health risk 
Study Subjects Intervention Results 
Body composition 
Carter et al. 
[61] 
Normal weight 
♀♂ 
22 ± 1 yrs 
N = 16 
Short-term progressive training on 
cycle ergometer 
Low-moderate intensity 
Lower FM post-
intervention 
 
Devries et al. 
[8] 
Normal weight 
and  obese ♀♂ 
20-55 yrs 
N = 41 
Long-term progressive training on 
cycle ergometer 
Low-moderate intensity 
No differences due to 
training or gender on BW 
Kraus et al. 
[51] 
Overweight ♀♂ 
52.3 ± 7.8 yrs 
Long-term, 3 activity levels: 
a) sedentary 
b) high intensity 
c) moderate intensity 
d) low intensity 
Lower BW post-
intervention in b) and d) 
compared to a) 
 
McKenzie et 
al. [62] 
Normal weight 
♀♂ 
26.9 ± 3.4 yrs 
N = 14 
Short-term training protocol on cycle 
ergometer 
Moderate intensity 
Lower FM post-
intervention 
 
Miyazaki et 
al. [63] 
Normal weight ♂ 
19-21yrs 
Long-term training protocol, running 
High intensity 
No difference in BW or 
FM post-intervention 
Blood lipids 
Kraus et al. 
[51] 
Overweight ♀♂ 
52.3 ± 7.8 yrs 
Long-term, 3 activity levels: 
a) sedentary 
b) high intensity 
c) moderate intensity 
d) low intensity 
No difference in LDL to 
TCHOL ratio between 
groups 
Lower LDL particle size 
in b), c) and d) than a) 
Metabolic markers 
Bruce et al. 
[64] 
Obese ♀♂ 
36 ± 3 yrs 
N = 9 
Short-term training on cycle ergometer 
Moderate intensity 
Lower plasma insulin 
post-intervention 
Devries et al. 
[8] 
Normal weight 
and  obese ♀♂ 
20-55 yrs 
N = 41 
Long-term progressive training on 
cycle ergometer 
Low-moderate intensity 
No differences in 
metabolic markers post-
intervention 
Devries et al. 
[44] 
Normal weight 
and obese ♀ age 
20-50 
N = 24 
Long-term progressive training on 
cycle ergometer 
Low-moderate intensity 
No difference in fasting 
glucose or insulin post-
intervention 
Inflammatory markers 
Bruce et al. 
[64] 
Obese ♀♂ 
36 ± 3 yrs 
N = 9 
Short-term training on cycle ergometer 
Moderate intensity 
Lower plasma adiponectin 
post-intervention 
Donges et al. 
[65] 
Overweight ♀♂ Short-term training protocol 
Moderate intensity 
Lower CRP  
Trend for lower IL-6 
Abbreviations: ♀ – females; ♂ – males; yrs – years; short-term: less than 12 week 
duration; long-term: 12 week duration or more; low intensity: 50% VO2peak or less; 
moderate intensity: 50-75% VO2peak; high intensity: 75% VO2peak or more; wk – week; 
mo. – month; min – minutes; mi/wk – miles per week; BW – body weight; FM – fat 
mass; TCHOL - total cholesterol; LDL – low-density-lipoprotein cholesterol; CRP – C-
reactive protein; IL-6 – interleukin-6  
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Figure 2. Proposed mechanisms through which lifestyle interventions may attenuate 
obesity-related risk factors. (Adapted from Vincent et al. [6].) 
 
Caloric restriction /    Exercise training  
Diet modification      Improved  
       body composition 
 
     ↓ Blood lipids   ↓ Leptin 
↑ Glycaemic control   (LDL, TGs, TCHOL) 
 
↓ Inflammatory cytokines 
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2.3.1 Bovine milk components and body composition  
In the past, dietary intake of bovine milk had been generally assumed to cause 
weight gain due to its high energy and fat content [66]. However, more recent research 
indicates that individuals who consume high amounts of dairy typically lose weight when 
dieting, and those who have successfully lost weight do not experience weight regain 
when consuming dairy [11, 21].  There is increasing evidence to show that consumption 
of dairy foods and dietary calcium is inversely related to obesity and is associated with 
positive effects on weight loss (see Table 1) [11-14, 19, 20, 36, 55].  Individuals who 
consume high amounts of dairy foods are at a 67% lower risk of gaining weight over the 
course of 10 years [11].  Researchers have looked at both human and animal models to 
determine whether calcium supplements alone are enough to elicit these beneficial effects 
or whether dairy, as a ‘whole food’, is preferable for improvements in body composition. 
For example, mice given a high calcium diet in the form of low fat dry milk had 
significantly reduced body weight when compared to mice on a control diet and mice on 
a high-calcium diet devoid of milk [19, 36, 67]. These findings suggest that, in mice at 
least, calcium-intake-induced weight loss is associated with milk as a whole food, rather 
than calcium as a stand-alone component.  Similar findings have also been observed in 
human subjects [11, 12, 16, 20]. Furthermore, increased calcium intake via dairy 
significantly reduced the amount of post-prandial lipid found in the blood while calcium 
supplementation alone did not [16]. Collectively, these observations suggest that other 
components of milk likely contribute to the weight-loss effect, possibly acting alone or in 
combination with calcium. These beneficial components of milk, including calcium, are 
collectively known as bioactive compounds, and are released through digestive processes 
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[21, 68]. Bioactive compounds can be defined as components of whole foods that may 
have regulatory effects beyond basic nutrition [68]. 
It should be noted that there is also evidence to show that increased intakes of 
calcium alone have beneficial effects on weight loss and body composition. Calcium 
intake of approximately 800mg per day appears to be the threshold for body composition 
benefits [11], but calcium intake via milk/dairy intake appears to be the most beneficial 
[11, 12, 16, 20].  According to the Dairy Farmers of Canada, a glass of milk contains 
about 300mg of calcium [69]. Therefore, drinking three servings of milk a day would 
provide the necessary calcium to achieve this benefit for body composition, and this is 
not taking into consideration any other dairy intake [11]. The mechanisms underlying 
how dairy calcium intake relates to weight loss and body composition have yet to be fully 
determined, although many different theories have been proposed. When dairy calcium is 
increased in mice this may prevent or reduce adiposity through interaction of calcium and 
lipids in the digestive tract, where high intestinal calcium concentrations lead to binding 
of calcium and fatty acids, creating ‘soaps’ which are indigestible [19, 70]. These soaps 
in turn lead to more lipid being excreted [19] leaving less lipid available for absorption 
and storage in adipose tissue. Interestingly, these mice were also more responsive to post-
prandial insulin secretion [19]. Similar responses have been seen in human subjects, 
where a diet high in dairy calcium increases the amount of fat excretion when compared 
to low dairy calcium diets (see Table 1) [11, 16, 21, 55]. Furthermore, increases in insulin 
sensitivity were also observed with the increased intake of dairy calcium [27]. Increased 
dairy-calcium intake has been shown to decrease low-density-lipoprotein (LDL) 
cholesterol (see Table 1) [55, 60, 66, 71, 72], potentially through excretion, indicating 
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that increased lipid secretion may be a possible mechanism for preventing or reversing 
elevated blood cholesterol. High calcium intake has also been negatively associated with 
high plasma lipids and lipoproteins [53, 66, 73].  
There is also evidence to suggest that the hormone calcitriol (1,25-
dihydroxyvitamin D) is inhibited by elevated dietary calcium intake [12, 13, 19, 36]. 
Calcitriol is perhaps most commonly known for its actions within the intestines and 
kidneys to promote absorption of calcium and phosphorus, and in bone metabolism 
regulation [74]. However, there is evidence to suggest that calcitriol also acts upon 
vitamin D receptors present in adipose tissue; when stimulated, these receptors act to 
increase intracellular calcium concentrations ([Ca
2+
]i) [20, 21, 67, 75]. When [Ca
2+
]i is 
high, lipogenesis is promoted through stimulation of fatty acid synthase, and lipolysis is 
inhibited [12, 13, 36]. When dietary calcium levels are high, calcitriol action upon 
adipose tissue is inhibited, thereby lowering [Ca
2+
]i and promoting lipid mobilization and 
reduction of adipose depots [12, 13, 36, 67, 75]. It is unclear if increased consumption of 
vitamin D-fortified dairy affects these processes. Taking these calcium-related 
mechanisms together, high dairy intake may reduce the overall amount of energy stored 
as white adipose tissue by increasing the amount of lipid excreted, reducing the amount 
of lipid absorbed and possibly reducing intracellular lipogenesis.  
Calcium is not the only bioactive component of milk that has health benefits. 
Other bioactive compounds include the peptides casokinins and lactokinins, which are 
created through the digestion of the milk proteins casein and whey [32, 68]. These 
particular bioactive peptides have been observed to have ACE (angiotensin-I-converting 
enzyme)-inhibitory effects [32, 66, 68, 76]. ACE has many functions, perhaps most 
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notably regulating blood pressure [38, 68, 76]. When left to function normally, ACE 
converts angiotensin-I into angiotensin-II, which is a vasoconstrictor. However, when 
ACE is inhibited, angiotensin-II is not formed which prevents the hypertensive effect, 
while the action of bradykinin is enhanced [38, 68, 76]. Bradykinin is a vasodilator, and 
the overall effect of ACE inhibition is the lowering of blood pressure [38, 66, 68, 76]. 
Angiotensin-II is also involved in increasing the expression of adipocyte fatty acid 
synthase, an enzyme which aids in fat deposition in WAT [12, 13, 20, 21]. In this way, 
dairy-based ACE inhibition has been suggested to be involved in metabolism regulation 
and may have a mild anti-obesogenic effect [12, 16, 20, 21, 38].  
Branched-chain amino acids (BCAAs) are another bioactive component of milk 
that appears to have anti-obesity effects [19-21, 77]. BCAAs are found in significant 
quantities in the milk proteins whey and casein, and they play a key role in protein 
metabolism and muscle protein synthesis [14, 20, 21, 66]. Because some of the proteins 
found in milk are ‘slow’ proteins – meaning they are slow to be digested and absorbed in 
the intestine – these proteins are present in the bloodstream for a prolonged period of time 
due to gradual intestinal uptake, providing a more sustained supply of amino acids for 
more effective muscle protein synthesis [66, 77-79]. Therefore, dairy represents a quality 
nutritional choice to fuel protein synthesis, and facilitating an enhanced protein balance. 
Considering the numerous beneficial components found within bovine dairy, it is 
important to establish how much dairy should be ingested to optimize the potential health 
benefits. Considering calcium alone as a bioactive compound in milk, it is well 
established that 3 servings (3 x 250 mL) of milk per day provides enough calcium to 
surpass the threshold of 800mg/day, considered to be optimal for body compositional 
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benefits [11, 69].  Looking at milk as a ‘whole food’, provision of three servings of dairy 
products per day over a span of 6 months has been shown to significantly reduce body 
weight when compared to a control group and a calcium-supplemented group (11.1 ± 
1.6kg lost vs. 6.6 ± 2.6kg and 8.6 ± 1.6kg, respectively) [58]. Three servings of dairy 
products per day have also been shown to reduce circulating TNF-α, IL-6 and CRP levels 
(~15%, 13% and 57%, respectively) over 28 days [37]. Another study compared two 
types of dairy products, looking at 2.5 servings daily of skim milk as opposed to whole 
milk, and found that after 6 weeks skim milk resulted in greater reductions in blood lipids 
and total cholesterol [60]. Taken together, these studies suggest that consumption of 
approximately 3 servings of dairy product per day, and skim milk in particular, appear to 
be effective for improvements in body weight and blood markers of inflammation, both 
contributing to overall health.   
In summary, bovine milk products contain many components that appear to be 
beneficial for health management. Milk contains components that contribute to weight 
loss and management, such as BCAAs, which are related to increases in lean body mass 
[14, 20, 21, 37, 66], and calcium, which increases fatty acid excretion and inhibits 
adipose accumulation [11-14, 16, 19-21, 36, 55]. In addition, milk contains nutrients 
which act to prevent or reduce the negative effects that are associated with being 
overweight or obese. These include hypertension and high cholesterol, and reductions in 
both of these negative factors have been associated with bovine milk components [32, 55, 
60, 66, 68, 71, 72, 76]. Taken together, bovine milk appears to be beneficial for weight 
management and the associated health problems when consumed in adequate amounts in 
humans.  
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2.3.2 Bovine milk components and inflammation  
Apart from weight loss, dairy foods and components have also been investigated 
in regards their effects on whole body inflammation and oxidative stress. In mice, high 
calcium intake in the form of low fat dry milk reduced inflammation, both systemically 
and more specifically in WAT [19, 36]. A possible explanation for this effect is that gene 
expression of inflammatory cytokines is inhibited when dairy is consumed, and TNF-α 
activity is suppressed [36]. Dairy consumption also results in increased amounts of 
adiponectin [2, 36], which, as previously stated, has anti-inflammatory effects. Dietary 
intake of the dairy fatty acids pentadecanoic acid and heptadecanoic acid are negatively 
associated with the inflammatory marker C-reactive protein (CRP) [7]. However, due to 
the very small amounts of these fatty acids present (0.21 ± 0.04% total phospholipid fatty 
acids present in milk) [7] it is unknown whether this effect is due to the fatty acids 
themselves or dairy intake in general. 
In humans, there is mixed evidence for dairy and dairy compounds having an 
effect on inflammation (see Table 1). In one study looking at supplementation with whey 
protein, the researchers noted no changes in TNF-α, IL-6 and CRP in obese individuals 
(BMI = 31.3 ± 0.8) [32, 80], whereas a different study observed no changes in 
inflammatory markers with casein supplementation [73]. Other studies indicate that dairy 
intake reduces whole-body inflammation and inflammation associated with various 
disease states such as insulin insensitivity/diabetes [27, 73, 81]. The discrepancies 
between these studies appear to be primarily due to the difference between 
supplementation with milk components and consumption of milk as a ‘whole food’ – the 
studies which saw no changes in inflammatory markers focussed on milk proteins 
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ingested as supplements, while the studies which did observe positive changes consumed 
milk. Based on these observations, investigation into the role of dietary intake of milk as 
a whole food represents an important area of study. 
2.3.3 Exercise and body composition  
Endurance exercise is a common intervention used for maintenance of a healthy 
body weight. Health Canada defines regular endurance exercise as 30-60min per day of 
light-moderate exercise at 50-65% of maximal heart rate (HRmax), approximately 5 days 
per week [82]. There is a negative correlation between amount of physical activity and 
measures of body fat – as physical activity increases, measures such as BMI and waist 
circumference decrease (see Table 2) [39]. Research indicates that individuals who 
participate in even moderate to low intensity activity (the caloric equivalent of walking 8-
12 miles per week at 40-50% peak oxygen consumption) experience weight loss in 
comparison to sedentary controls, suggesting that any amount of activity is beneficial for 
achieving healthy weight status [51].  
 The risk of developing various diseases, such as diabetes, cardiovascular disease, 
hypertension and certain cancers, is greatly decreased in individuals who engage in 
regular physical activity [50], and it can prevent or reduce excessive adiposity [8, 50].  In 
regards to diabetes, engaging in regular physical activity/exercise results in a reduction of 
resting plasma insulin levels [64], indicating that less insulin is required to elicit a 
reduction in blood glucose (increased insulin sensitivity), and may also contribute to 
decreasing the chances of developing insulin resistance and eventually type II diabetes. 
This effect appears to be independent of weight loss [64]. There is also a general 
consensus that regular exercise can favourably decrease the amount of circulating lipids 
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in the bloodstream [23, 83]. Furthermore, engaging in long-term endurance exercise has 
been shown to increase concentrations of HDL cholesterol, while exercise-induced 
weight loss can reduce unhealthy cholesterol and the risk associated with high cholesterol 
levels [23, 83]. This effect is likely due in part to an exercise-induced change in the blood 
distribution of lipoproteins, as research indicates that long-term exercise results in a shift 
in the distribution towards higher density lipoprotein particles that are less likely to block 
arteries [23, 51]. These observations suggest that exercise is linked to reduced risk of 
diseases associated with high adiposity and BMI. 
In addition to reduced adiposity and disease risk, exercise contributes to healthy 
body composition through increased energy turnover. Endurance training reduces 
reliance on both carbohydrate, in the forms of glucose and muscle glycogen, and amino 
acids as fuels, and increases the reliance on lipids as a source of fuel for muscle activity 
[61, 62, 64, 84] for a given absolute intensity. As a fuel for activity, lipids come from 
within the muscle itself (intramuscular triglycerides) and are also mobilized from adipose 
tissue [25]. Increased use of lipids as fuel maybe partially mediated through healthy 
circulating adiponectin levels [64], which have been shown to improve with decreased 
body weight and increased dairy intake [2, 36].  
In summary, participation in regular exercise results in various adaptations that 
relate directly to body composition and energy metabolism. Furthermore, these 
adaptations appear to be beneficial not just for body weight management, but for also for 
reduction in disease risk. 
2.3.4 Exercise and inflammation  
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Acute bouts of exercise; whether endurance or resistance, maximal or 
submaximal, have all been shown to result in an increase in inflammation after activity 
cessation (see Table 2) [2, 17, 85]. There is debate as to whether this inflammatory 
response is due to muscle tissue damage as a direct result of exercise, or due to damage 
caused by increased reactive oxygen/nitrogen species (RONS) production [85]. However, 
there is evidence to indicate that long-term training protocols result in reduced 
inflammatory markers at rest, indicating a beneficial effect of exercise [2, 17, 26, 44]. 
There are a few possible mechanisms for the reduction in basal inflammatory markers. 
One possibility is through the reduction of adipose tissue typically seen with long-term 
exercise: as the volume of adipose tissue decreases, the amount of inflammatory 
cytokines secreted also decreases, resulting in an overall reduction in whole body 
inflammation [17, 44]. Interestingly, regular participation in exercise has been observed 
to reduce CRP levels in the blood even if there were no changes in body mass or body 
composition [26], indicating that there may also be a weight-independent mechanism. 
Furthermore, exercise induces release of IL-6 and up regulates IL-6 mRNA in skeletal 
muscle [39]. Although IL-6 is considered to be a pro-inflammatory marker, when it is 
released during exercise it acts as an anti-inflammatory agent, and also inhibits the effects 
of TNF-α [39]. Taken together, this evidence indicates that repeated exercise 
participation (training) is a useful method of reducing inflammatory markers and 
increasing anti-inflammatory agents. 
2.3.5 Bovine milk and exercise in combination  
As previously discussed, weight loss - whether due to increased physical activity 
or dietary interventions - has the beneficial effect of reducing whole-body inflammation 
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and inflammatory markers [2, 31]. Considering that both bovine milk and aerobic 
exercise produce this beneficial effect independent of one another, the natural next step is 
to investigate their combined effects and determine if their effects are additive.  
When increased dairy consumption is combined with long-term endurance 
exercise, there appears to be an effect of reducing muscle catabolism and encouraging 
muscle protein anabolism, facilitating gains in lean muscle [86-88]. These results indicate 
that protein, specifically BCAAs, are an important component of exercise-related 
nutrition, and it has been suggested by some that they should be included in any foods or 
beverages consumed for exercise preparation and recovery [87, 88]. Other studies have 
found increased insulin sensitivity and reduced inflammation in response to the 
combination of dietary and exercise interventions in individuals who are obese [6, 88]. 
ACE inhibition, as has been previously outlined to be one of the possible benefits of dairy 
consumption, has also been shown to improve endurance exercise capacity in rats [89]. 
Interestingly, many high-level endurance athletes have a natural inhibition of ACE due to 
genetic traits [89-91], suggesting that ACE inhibition may facilitate endurance capacity.    
Milk also has many components that are important for endurance exercise 
recovery, including carbohydrates and proteins previously mentioned, as well as 
electrolytes, vitamins and minerals [66, 77, 92]. Milk protein is important in exercise 
recovery to provide a more prolonged elevation of blood amino acids, possibly 
facilitating protein synthesis in muscle [77]. Some work has shown that consuming 
chocolate milk (1% milk fat) in conjunction with exercise increases fatty acid circulation 
in the blood, which may allow for individuals to engage in exercise for a longer period of 
time due to the higher readily available fuel, which in turn will prolong the beneficial 
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effects of acute exercise [84, 88]; however, this effect is not present when consuming low 
fat or skim milk. Milk also serves to replenish fluids and electrolytes lost as sweat during 
exercise, maintaining healthy fluid balance throughout exercise (when ingested prior to 
and during activity) and during recovery from exercise (when ingested immediately post-
activity) [77, 84, 92, 93]. Milk as a post-exercise beverage has also been observed to 
blunt the muscle damage response to acute exercise [94, 95].  Muscle damage can occur 
when an individual undertakes any form of unhabituated activity, whether it be beginning 
a new exercise protocol, changing a habitual exercise routine, or simply shovelling snow 
for the first time that season, and the probability and severity of damage increases with 
intensity and duration of activity [96]. Suggested causes of muscle damage also include 
substrate depletion and RONS within the muscle [96]. Damage is characterized by edema 
and increased levels of myoglobin and creatine kinase in the blood, and can lead to 
transitory pain and decreased strength and function [95, 96]. The specific mechanisms 
underlying this possible role in the prevention of muscle damage remains unclear; 
however, one theory that has been suggested is that milk intake possibly blunts these 
effects due to adequate provision of amino acids needed to replace the proteins degraded 
due to activity, and provision at the time of need [95]. Clearly, further research is needed 
to better understand the role of milk intake and muscle damage following physical 
activity. 
There is a plethora of research regarding the benefits of resistance training for 
overweight and obese individuals, both with and without dietary interventions. One 
review paper noted that the overall trend of current research indicates a beneficial effect 
in weight management, lean mass gains, and reduced inflammatory markers due to 
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resistance training [26]. There are conflicting reports regarding the efficacy of dairy 
supplementation in conjunction with resistance training for improved health in both 
athletes and sedentary populations [97-100]. However, for acute anaerobic exercise, dairy 
has been shown to have benefits for blunting muscle damage and associated soreness, as 
well as being effective at contributing to rehydration and replenishment of substrates used 
during exercise [77]. 
2.3.6  Timing of nutritional intervention 
It is well established that there are numerous benefits associated with dairy intake 
for body composition and other health considerations. Considering this, it is important to 
determine whether the timing of dairy intake is an important factor when coupled with 
endurance exercise training. Determining the timing of intake is an important component 
of these interventions in order to maximize any potential health benefits and adaptations.  
Much of the research into this area indicates that nutritional intake within 60 
minutes of exercise cessation – typically within the first hour – has benefits ranging from 
optimization of muscle glycogen resynthesis, reduction of muscle protein degradation as 
well as improved muscle protein synthesis [101, 102].  In a study that looked at intake of 
a beverage containing carbohydrate, protein and fat at breakfast versus immediately post-
exercise, the group who received their drink post-exercise showed improved recovery 
when compared to those who took their beverage at an alternate time [101]. Interestingly, 
this beverage also offset the drop in body mass associated with an increase in activity, 
which was seen in the control group [101]. A similar study, using a carbohydrate-protein 
supplemental beverage, found that muscle damage was attenuated to the greatest extent 
by consuming the beverage immediately post-exercise [87]. In contrast, a study looking 
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at intake of protein from various sources, including skim milk, there were no differences 
in the availability of amino acids in the blood when comparing intake from rest or post-
exercise [103]. However, these studies all focused on individuals who are already active 
and so their results cannot easily be extrapolated to indicate how nutrient timing would 
affect overweight and inactive individuals, whether for exercise recovery or for any other 
benefits.  
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3. Statement of the Problem 
Considering the research on exercise and dairy products, alone and in 
combination, on weight management and/or inflammation, there is a growing amount of 
evidence to indicate that these interventions alone are likely effective strategies to 
possibly attenuate or even alleviate these problems. However, there are gaps in the 
literature when it comes to research looking at the influence of combining these 
interventions and determining the outcomes on risk factors. While many studies have 
investigated the effects of dairy on inflammation and blood lipids in combination, or 
dairy and exercise for weight loss, to the author’s knowledge there have been no 
investigations into the effect of combining increased low fat dairy intake and endurance 
exercise on weight loss, inflammation, blood lipids and metabolic markers in overweight 
individuals. The exercise-based research typically involves resistance exercise, with and 
without milk, which does provide some insight into general exercise benefits, but there is 
not as much research looking at endurance exercise for these health factors, and 
particularly little research looking at endurance exercise and increased milk intake. 
Research that does utilize milk intake with endurance exercise training typically 
investigates milk for acute recovery rather than for long-term health. Until endurance 
training and increased dairy intake are studied in these contexts, our understanding of the 
health benefits and mechanisms remain incomplete. This is an important area 
investigation due to the growing incidence of obesity. Determining the effects of 
endurance training and dairy intake in overweight individuals is critical as endurance 
exercise represents a form of activity that leads to greater total amounts of energy 
turnover, as compared to resistance exercise, and combined they may represent simple, 
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cost effective and relatively easy lifestyle modifications that could work synergistically to 
benefit this population, helping to prevent obesity. 
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4. Purpose 
The purpose of this proposed study was to increase both daily physical activity, in 
the form of endurance exercise training, and dairy intake, and to determine the combined 
effects of these factors. Furthermore, we wanted to determine if the timing of intake of 
milk is critical in facilitating enhanced adaptations. More specifically, our measures 
include changes in body composition, VO2peak, blood lipids, metabolic markers, and 
whole body inflammation, resulting from these interventions. 
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5. Hypothesis  
Overall, we hypothesized that combining increased low fat milk (LFM) intake 
with endurance exercise training would augment the physiological and health-related 
adaptations that would be experienced with either intervention alone. We hypothesized 
that these adaptations would include: improved body composition, with decreased body 
fat and increased lean mass; improved blood-lipid measures; improved metabolic 
measures; and decreased whole body inflammation.  
Specifically, we hypothesized that three servings of LFM consumed immediately 
after endurance exercise cessation would lead to augmented adaptations when compared 
to: a) LFM consumption 4 hours before or 6 hours after endurance exercise participation; 
b) consumption of an isoenergetic carbohydrate beverage within an hour of exercise 
cessation; or c) consumption of an isoenergetic carbohydrate beverage either 4 hours 
before or 6 hours after exercise participation. These augmented adaptations were 
hypothesized as follows:  
A) Mild weight loss, or in absence of weight loss, a shift toward lower FM and 
higher LM, 
B) Reduction of whole body inflammation and inflammatory markers and 
associated health risk markers as follows: 
a. Reduced blood lipids – total cholesterol, HDL, LDL and triglycerides 
b. Lower metabolic markers at rest – insulin, glycogen, and leptin  
As a secondary investigation, we wanted to determine if the groups ingesting 
milk, and the resulting elevated intakes of both calcium and vitamin D, would exhibit 
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correspondingly higher levels of circulating serum-25(OH)D in comparison to those 
ingesting the carbohydrate beverage within the time frame of the current investigation. 
We also anticipated that all groups would experience increases in VO2peak measures due 
to training.  
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6. Methods   
6.1 Participant recruitment 
We recruited 40 untrained university-aged males whose BMI fell in the range of 
22-33 (refer to Table 3 for participant baseline characteristics). This was accomplished 
through advertising on Brock University campus through posters, word of mouth and on 
the Brock University webpage. Interested individuals contacted the study organizers and 
an initial interview was scheduled, during which time individuals were provided with an 
informed consent form which outlined in detail the purpose and methods of the study. 
This information was also provided verbally. Interested individuals were asked to 
complete a medical history, a dairy intake questionnaire to confirm habitual intake, and a 
physical-activity readiness questionnaire (PAR-Q) to confirm applicability for exercise 
involvement. Their height and weight were taken to determine BMI. Participants were 
accepted into the study if they had no medical conditions that would prevent them from 
engaging in regular exercise, were not allergic to dairy products, did not exercise 
regularly and did not consume more than three servings of dairy products per day.  
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Figure 3. Outline of experimental protocol.  
 
 
Abbreviations: DXA – Dual X-ray absorptiometry; d/wk – days per week; hr/d – hour per 
day; HRmax – maximal heart rate; hrs - hours 
 
 
Participant 
Recruitment 
– 
Informed Consent  
(n = 40) 
Pre-test Measures (n = 39) 
– 
VO2peak, Blood draw, DXA,  
Food-log 
Participant Randomization into Groups: 
Dairy-Exercise-Immediate (DEI);  
Dairy-Exercise-Alternate (DEA); 
CHO-Exercise-Immediate (CEI);  
CHO-Exercise-Alternate (CEA) 
DEI (n=9) and CEI (n=8) groups: 
12 weeks training begins (5d/wk, 1hr/d,  
50-60%HRmax) 
Beverage consumed immediately post-exercise  
DEA (n=10) and CEA (n=10) groups: 
12 weeks training begins (5d/wk, 1hr/d,  
50-60%HRmax) 
Beverage consumed 6hrs post-exercise  
  
Post-test Measures (n = 23) 
– 
VO2peak, Blood draw, DXA,  
Food-log 
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6.2 Pre-testing measures 
Once accepted into the study, participants returned to the lab to complete a maximal 
oxygen consumption test on a cycle ergometer, to determine VO2peak. This test involved 
a 2-minute warm up at 80W, after which the test started; the participant cycled for 2 more 
minutes at 80W, and then the wattage was increased by 20W every 2 minutes. This 
continued until exhaustion or until cycling cadence dropped below 60rpm and the 
respiratory exchange ratio was above 1.12; at this time the maximal oxygen consumption 
was taken as VO2peak. Verbal encouragement was given throughout this test. Participants 
also completed a 4-day food log (3 week days and one weekend day) in order to estimate 
regular dietary patters and verify daily dairy consumption. Food logs were analyzed using 
dietary analysis software (Nutritionist Pro, Version 2.2, First DataBank Inc., San Bruno, 
CA, USA). Participants were then randomized into one of four experimental groups, 
insuring that all groups were matched for clinical BMI range (20-24.9, 25-29.9, 30-34.9). 
The four experimental groups were: Dairy-Exercise-Immediate (DEI), Dairy-Exercise-
Alternate (DEA), Carbohydrate-Exercise-Immediate (CEI), and Carbohydrate-Exercise-
Alternate (CEA). Participants were blinded to the purpose of the study being an 
investigation of dairy intake, having been told that we were investigating ‘sports 
beverages’, and were also blinded as to which experimental group they were randomized 
into. 
On subsequent lab visits, a fasted blood sample was taken and a dual X-ray 
absorptiometry (DXA, Lunar, GE) scan was completed. DXA scans were used to 
determine body composition. Fasting blood samples were collected from the antecubital 
vein into Vacutainer© tubes containing sodium heparin for plasma collection, and into 
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untreated tubes for serum collection. Plasma tubes were placed on ice, centrifuged at 
2500 g for 15 min at 5ºC, and aliquoted into 1.5ml tubes and stored at –86ºC for 
subsequent analysis.  Serum tubes were allowed to stand at room temperature until 
clotted, centrifuged at 2500 g at 5ºC for 15 min, aliquoted into 1.5ml tubes and stored at –
86ºC for subsequent analysis.  
 
6.3 Training protocol and post-testing measures 
Once all the pre-testing measures were completed, participants engaged in an 
endurance exercise training program on stationary bicycle ergometers (Monarch 
Ergomedic 828 E, Sweden), for one hour each day, five days a week for 12 weeks. This 
exercise took place at the Brock Research and Innovation Centre. During the first three 
weeks, participants cycled at an intensity of 50% their max heart rate (as determined 
during the VO2peak test), and then at 60% for the remaining 9 weeks. These relative heart 
rates were chosen to ease the participants into exercising, rather than asking sedentary 
individuals to begin training at a higher heart rate and intensity. Senior undergraduate 
research assistants who had experience in exercise prescription and personal training 
directly supervised all training to ensure the protocol was followed and performed at the 
correct workloads for the set amount of time. Different research assistants were 
responsible for managing beverage provision and administration. Participants in the DEI 
group were given 750mL of LFM (3 additional dairy servings per day), which was 
consumed immediately after exercise (complete consumption within 60min of training 
cessation). The DEA group also received 750mL of LFM, but to be consumed at an 
unrelated time of day. The CEI group received an isocaloric carbohydrate (maltodextrin) 
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beverage to be consumed within the hour following exercise. Participants in the CEA 
group were asked to consume their carbohydrate beverage at an unrelated time of day. 
Participants in the DEA and CEA groups were given the choice of consuming their 
beverages either 4 hours prior to their training or 6 hours after training. All individuals 
opted to consume their beverages 6 hours after exercise cessation. Both beverage types 
were the same volume (750mL) and contained approximately the same amount of energy 
– dairy groups consumed approximately 270kcals and carbohydrate groups consumed 
approximately 240kcals per day. Participants were blinded to their groups and asked not 
to discuss their beverages with other participants. To aid the blinding process, all drinks 
were flavoured with non-caloric vanilla flavouring and were administered in opaque 
bottles. Participants were encouraged to maintain consistent dietary patterns throughout 
the study period.  During the last week of training, participants were asked to complete 
another 4-day food log to determine if any changes in habitual nutritional intake had 
occurred over the course of the study.  
 Once the twelve weeks of training were completed, participants underwent the 
same tests that were administered prior to training. All post-testing measures began 
within the last week of training. 
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7. Analysis  
Body composition data obtained before and after training from DXA were 
compared, as well as absolute and relative VO2peak results and maximal heart rate. 
 Blood lipid analysis, including total cholesterol, low-density lipoprotein 
cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglycerides (TGs) 
concentrations, were analyzed in serum samples to examine blood lipid profile 
alterations. This analysis was performed by the clinical chemistry lab at McMaster 
University, Hamilton, Ontario.   
Serum samples were used to determine changes in IL-6, glucose, insulin, TNF-α, 
CRP and leptin using Millipore Milliplex® kits and MagPix software, and vitamin D 
using an ELISA kit (ALPCO
TM
 Immunoassays, Salem, NH).  
The graduate students running the study performed the majority of the analyses, 
and as such, blinding during this process was not possible. However, the technicians 
assisting the graduate students with the analyses were not involved with the training 
portion of the study and therefore blinded to participant groupings. The blood-lipid 
analyses were the only analyses that were truly double-blinded, as the McMaster 
technicians performing these analyses were only given the participant numbers for the 
serum being analyzed and had no other contact with the study. 
As an estimate of insulin resistance, we calculated the homeostatic model 
assessment (HOMA) index, which is defined as the product of the fasting plasma insulin 
level (μU/mL) and the fasting plasma glucose level (mmol/L), divided by 22.5 [104]. In 
order to have serum glucose values to use in this calculation, glucose was determined 
using a colorimetric assay (Cayman Chemical Co., Ann Arbor, MI).  
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All data were analyzed using a three way-ANOVA (beverage type, intake time, 
pre-test/post-test) with repeated measures. A Tukey’s Honest Significant Difference test 
was used to establish pair-wise differences when significant interactions were observed (p 
≤ 0.05). A two way-ANOVA (beverage type, intake time) was also performed using delta 
values, which were determined by subtracting the pre-test value from the post-test value 
for each outcome variable.  
 Results are expressed as mean ± standard error, unless otherwise stated. Statistical 
analyses were performed with Statistica software for Windows, version 5.0 (StatSoft, 
Inc., Tulsa, OK).  
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8. Results 
8.1 Baseline  
Forty participants enrolled in the study, and twenty-three participants completed 
the entire protocol. Data from one participant was excluded from statistical analysis due 
to pulmonary illness at the time of post-testing, leaving a final n of 22. The baseline 
characteristics for the participants who completed the study are described in Table 3. 
There were no significant differences between the different experimental groups at 
baseline.  
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Table 3. Baseline characteristics for individuals who completed the study, by group 
 DEI (n=7) DEA (n=5) CEI (n=6) CEA (n=4) p-value 
Subject Characteristics: 
Age (yrs) 
 
23.7 ± 2.5 20.6 ± 2.5 24.4 ± 3.0 29.4 ± 3.5 0.319 
Mass (kg) 
 
79.5 ± 3.5 83.5 ± 5.6 90.6 ±6.0 86.2 ±4.2 0.422 
Absolute VO2peak
 (L/min) 
 
3.7 ± 0.2 3.3 ± 0.2 3.9 ± 0.4 3.1 ± 0.4 0.540 
Relative VO2peak
 (ml/kg/min) 
46.9 ± 1.9 40.0 ± 5.0 43.8 ±7.5 35.3 ± 4.0 0.816 
Habitual Diet: 
Daily Energy Intake 
(Kcal) 
 
2845 ± 424 2215 ± 297 2373 ± 531 2641 ± 395 0.275 
%Carbohydrate 
 
52.8 ± 1.6 54.8 ± 5.6 46.0 ±3. 40.5 ± 2.5 0.358 
%Fat 
 
30.7 ± 2.0 31.0 ± 5.2 35.9 ± 2.7 41.1 ± 4.5 0.560 
%Protein 14.4 ± 0.9 14.2 ± 1.9 17.3 ± 1.1 18.5 ± 2.0 0.694 
Abbreviations: DEI – Dairy-Exercise-Immediate group; DEA – Dairy-Exercise-Alternate 
group; CEI – Carbohydrate-Exercise-Immediate group; CEA – Carbohydrate-Exercise-
Alternate group; yrs – years; kg – kilograms; ml/min – millilitres per minute; ml/kg/min – 
millilitres per kilogram body weight per minute; Kcal – kilocalories.  
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8.2 Dietary intake 
Participants were asked to maintain their habitual dietary intakes over the course 
of the study. Comparing the baseline food log and the post-training food log, there were 
no significant differences between groups or time points for absolute intake of energy, 
measured in kilocalories. There were also no significant differences for macronutrient 
intake between groups or time points (Table 4). These results do not include the exercise 
beverage administered during the course of training. The DEI and DEA groups were 
consuming an additional 270kcal, 39g carbohydrate and 27g protein on training days, 
whereas the CEI and CEA groups were consuming an addition 240kcal and 60g 
carbohydrate on training days. When participant intake was analyzed with the beverage 
added to the post-training food log, there were still no significant differences in total 
energy intake between groups or time points, and no significant differences between 
energy intake from macronutrients.  
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Table 4. Change in energy and macronutrient intake over training intervention. 
Dietary Intake 
per day 
Dairy  CHO  
Immediate (n=7) Alternate (n=5) Immediate (n=7) Alternate (n=4) 
Kcal -915 ± 446 408 ± 116 64 ± 371 -476 ± 327 
CHO (Kcal) -555 ± 250 476 ± 191 73 ± 202 0 ± 107 
CHO (g) -139 ± 62 119 ± 48 18 ± 51 -1 ± 27 
PRO (Kcal) -120 ± 64 50 ± 32 -99 ± 83 -73 ± 42 
PRO (g) -30 ± 16 13 ± 8 -25 ± 21 -18 ± 10 
FAT (Kcal) -143 ± 116 79 ± 144 1 ± 170 -447 ± 355 
FAT (g) -16 ± 13 9 ± 16 0 ± 19 -50 ± 39 
Abbreviations: Kcal: kilocalorie; CHO: carbohydrate intake; PRO: protein intake; FAT: 
fat intake; g - grams. No significant differences between groups or time-points. 
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Dietary intake of the micronutrients vitamin D and calcium were also analyzed. 
Participants were ingesting an average of 140 IUs of vitamin D in their diets per day 
(DEI: 93.7 ± 17.9 pre, 171.7 ± 76.8 post; DEA: 103.7 ± 36.2 pre, 125.6 ± 38.3 post; CEI: 
123.8 ± 27.0 pre, 172.0 ± 38.9 post; CEA: 166.2 ± 17.2 pre, 155.7 ± 35.6 post) – there 
were no significant differences between groups or time points for this measure. However, 
this does not include the approximate 300 IU/day of vitamin D the DEI and DEA groups 
were consuming with their beverage [105]. When the fortified vitamin D in the dairy 
beverages was included in the statistical analyses for intake, there was a significant 
interaction between group by beverage type and time point. Post-hoc analyses indicated 
that the dairy beverage groups had significantly higher vitamin D intakes per day post-
intervention than the carbohydrate groups at both time points (p < 0.001) and that the 
vitamin D intake of the milk groups was significantly higher post-intervention than at 
baseline (p < 0.001). Despite the significant changes in vitamin D intake for the DEI and 
DEA groups, serum-25-(OH) D3 status remained unchanged for the different groups and 
time points, although there was a trend toward significance for the CEA group to have 
lower 25-(OH) D3 levels overall than any other group (p = 0.07). However, this trend 
could not be attributed to the intervention, and it should be noted that the CEA group had 
the smallest n (DEI: n = 7, DEA: n = 5, CEI: n = 6, CEA: n = 4). When the deltas were 
analyzed, there was no significant difference between groups (Figure 4). 
Mean levels of serum-vitamin D for all groups fell within the reference interval of 
20-140nmol/L. However, mean values tended to be at the lower end of this interval, 
falling between the categories of ‘very deficient’ (<30nmol/L) and ‘insufficient’ (30-
75nmol/L). Intra and inter coefficient of variances (CVs) were determined for our vitamin 
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D measures. Intra CVs for vitamin D were 3.6% (Plate 1) and 6.2% (Plate 2), while the 
inter-plate CV was 4.9%.  
The habitual baseline dietary calcium intake was also not significantly different 
between groups or time points. When the additional calcium intake from the milk 
beverages was taken into account, there was a significant interaction between group by 
beverage type and time point. Post-hoc analyses indicated that the dairy beverage groups 
had significantly higher calcium intakes per day than the carbohydrate groups at both 
time points (p < 0.05) and that the calcium intake of the milk groups was significantly 
higher post-intervention than at baseline (p < 0.001). 
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Figure 4. Change in serum-25-(OH)D3 by group. 
Abbreviations: DEI – Dairy-Exercise-Immediate group; DEA – Dairy-Exercise-Alternate 
group; CEI – Carbohydrate-Exercise-Immediate group; CEA – Carbohydrate-Exercise-
Alternate group. DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 4. No significant 
differences between groups or time-points.  
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8.3 Endurance exercise capacity markers 
Following completion of the training, there was no significant difference in 
endurance capacity between groups or time points as measured by maximal heart rate. In 
contrast, there was a significant main effect for relative VO2peak (ml/kg/min), VO2peak 
relative to lean mass (ml/kg LM/min) and absolute VO2peak (ml/min) by supplement 
timing, such that the groups ingesting the beverage immediately post-training had a 
higher overall VO2peak than those ingesting the beverage at an alternate time. This main 
effect was seen when we analyzed pre- and post-intervention values, rather than the delta 
values, and cannot be attributed to the intervention as it reflects subject characteristics 
rather than change over time. As expected, there was also a main effect for relative 
VO2peak by time point, such that all groups exhibited an increase in relative VO2peak 
post-intervention when compared to baseline (p < 0.01) (see Figure 5B). When the delta 
values for relative VO2peak post-intervention were compared to baseline, there were no 
significant differences between the groups; all groups increased by similar amounts. The 
main effect for time was not apparent when considering absolute VO2peak or VO2peak 
relative to lean mass values (Figure 5C), although the change from baseline did exhibit a 
notable trend for absolute VO2peak (p = 0.07) (Figure 5A). 
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Figure 5. Influence of beverage type and intake timing on change in VO2peak measures. 
Absolute VO2peak (A), relative VO2peak (B) and relative VO2peak to lean mass (C).  
* Main effect for increase in relative VO2peak from baseline (p < 0.05). δ Trend toward 
significance for increase in absolute VO2peak from baseline (p = 0.07). DEI: n = 7. DEA: 
n = 5. CEI: n = 6. CEA: n = 4. Abbreviations: DEI – Dairy-Exercise-Immediate; DEA – 
Dairy-Exercise-Alternate; CEI – Carbohydrate-Exercise-Immediate; CEA – 
Carbohydrate-Exercise-Alternate; L/min – litres per minute; ml/kg/min – millilitres per 
kilogram per minute; ml/kg LM/min – millilitres per kilogram of lean mass per minute  
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8.4 Body composition 
There were no significant differences in changes in body composition or fat mass 
between groups (see Figure 6A and B). However, a main effect for time in regards to lean 
mass was observed – all groups had a similar significant increase in lean mass following 
the training (p<0.05) (see Figure 6C). When delta values were analyzed, no significant 
differences were noted, indicating that all groups increased lean mass by approximately 
the same amount. 
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Figure 6. Influence of beverage type and intake timing on changes in body composition. 
Body mass (A), fat mass (B), and lean mass (C). 
* Main effect for increase in lean mass values from baseline (p < 0.05). DEI: n = 7. DEA: 
n = 5. CEI: n = 6. CEA: n = 4. Abbreviations: DEI – Dairy-Exercise-Immediate; DEA – 
Dairy-Exercise-Alternate; CEI – Carbohydrate-Exercise-Immediate; CEA – 
Carbohydrate-Exercise-Alternate; g – grams.  
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8.5 Blood lipids 
A significant main effect for group was observed for total serum cholesterol levels 
– the DEI and CEI groups had lower total serum cholesterol concentrations overall than 
the DEA and CEA groups (p<0.05) irrespective of time; however, this difference could 
not be attributed to the intervention. A similar main effect was also seen for serum LDL 
cholesterol; again, this difference could not be attributed to the intervention. Despite the 
main effects for serum total cholesterol and LDL cholesterol, no significant differences 
for any other blood lipid measures were observed (see Table 5). When delta values were 
analyzed, no differences between groups were noted for total cholesterol (Figure 7) or 
any other blood lipid measures. Mean values for the DEI, DEA and CEI groups fell in the 
desirable ranges for total cholesterol (<5.2mmol/L) and triglycerides (<1.7mmol/L) at 
both baseline and post-intervention. The CEA group fell outside these ranges at both time 
points, although it should be noted that this group was both the smallest (n = 4) and had 
the highest average age. At both time points, all groups exhibited HDL values that were 
lower than the desirable range of ≥1.3mmol/L. The DEI, DEA, and CEI groups had LDL 
values that were higher than the desirable range, but still within the range of ‘low risk’ 
classification (<3.4mmol/L) at baseline and post-intervention. However, the CEA group 
had LDL values that fell just above the ‘low risk’ range (baseline: 3.5mmol/L; post-
intervention: 3.6mmol/L). 
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Figure 7. Influence of beverage type and intake timing on change in total blood 
cholesterol concentration.  
DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 4. Abbreviations: DEI – Dairy-Exercise-
Immediate; DEA – Dairy-Exercise-Alternate; CEI – Carbohydrate-Exercise-Immediate; 
CEA – Carbohydrate-Exercise-Alternate; mmol/L – millimoles per litre 
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Table 5. Influence of beverage type and intake timing on change in serum lipids. 
Marker 
(mmol/L) 
Dairy  CHO  
Immediate (n=7)* Alternate (n=5) Immediate (n=7)* Alternate (n=4) 
TCHOL 0.04 ± 0.16 0.23 ± 0.34 0.12 ± 0.16 -0.04 ± 0.11 
LDL 0.02 ± 0.18 0.20 ± 0.28 0.11 ± 0.10 -0.05 ± 0.11 
TGs -0.34 ± 0.45 -0.04 ± 0.22 -0.06 ± 0.14 0.38 ± 0.62 
HDL 0.01 ± 0.04 -0.01 ± 0.05 0.04 ± 0.07 0.04 ± 0.06 
Abbreviations: TCHOL: Total cholesterol; LDL: Low-density lipoprotein cholesterol; 
TGs: Triglycerides; HDL: High-density lipoprotein cholesterol. *TCHOL and LDL 
values were significantly lower overall for DEI and CEI groups in comparison to DEA 
and CEA groups (p < 0.05); this finding is not attributable to the intervention. No other 
significant effects noted.  
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8.6 Inflammatory markers 
In regards to the serum inflammatory markers TNF-α (Figure 8A) and CRP 
(Figure 8B), no significant differences where observed between the experimental groups 
or at the different time points. Analyses of delta values (post-test value minus pre-test 
value) confirmed this result. Interestingly, serum concentrations of IL-6 were below the 
level of detection for the method used for all except for two of the participants, and as 
such no statistical analysis of IL-6 could be performed.  For the anti-inflammatory serum 
marker adiponectin (Figure 8C), there was a main effect for time, such that all groups 
demonstrated a decrease in serum adiponectin following the intervention (p < 0.05). 
Statistical analysis of delta values for this marker indicated that each group experienced a 
statistically similar decrease in adiponectin level.  
At both baseline and post-intervention, mean levels for both CRP and TNF-α 
were within healthy ranges (<10mg/L and <11.2pg/ml respectively). Mean adiponectin 
levels were higher than normal (3.7-5.7μm/ml) for all groups at both time points. 
Coefficient of variances (CVs) were determined within each plate and between plates. 
For TNF-α we achieved CVs of 2.2% (Plate 1) and 16.2% (Plate 2), for an inter-plate CV 
of 9.2%. For CRP we achieved CVs of 5.8% (Plate 1) and 8.2% (Plate 2), for an inter-
plate CV of 6.6%. For adiponectin we achieved CVs of 7.5% (Plate 1) and 7.4% (Plate 
2), for an inter-plate CV of 7.4%.  
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Figure 8. Influence of beverage type and intake timing on change in inflammatory 
markers. Inflammatory markers TNF-α (A) and CRP (B), and anti-inflammatory marker 
adiponectin (C). 
* Main effect for reduction in adiponectin levels from baseline (p < 0.05). DEI: n = 7. 
DEA: n = 5. CEI: n = 6. CEA: n = 4. Abbreviations: TNF-α: Tumor-necrosis-factor-
alpha; CRP: C - reactive protein; pg/ml – picograms per millilitre; ng/ml – nanograms per 
millilitre.  
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8.7 Metabolic markers 
There were no significant differences between groups for glucagon or insulin. 
Similarly, there were no significant changes in leptin levels between groups. Refer to 
Table 6 for delta values of these markers. As there were no significant interactions for 
either resting glucose or resting insulin levels, fasting glucose values were determined 
and the homeostasis model assessment (HOMA) index was calculated for each 
participant as an estimate of insulin resistance. There were no significant differences 
between groups or time points for the HOMA index. However, most groups had a trend 
for lower HOMA index value post-intervention than at baseline (p = 0.08). Furthermore, 
no groups had HOMA index values that were around the insulin-resistance cut-off point 
of approximately 3 [104].  
At both baseline and post-intervention the DEI, CEI and CEA groups had mean 
values of glucagon that fell within the reference range (<60pg/ml), while the DEA group 
had mean glucagon values that were higher than this range (84.5pg/ml at baseline, 
64.8pg/ml post-intervention). Mean insulin values for all groups fell within the reference 
range for insulin (3-25μIU/ml) at both time points, as did leptin values (0.6-36.4ng/ml). 
Coefficient of variance (CV) was determined for each plate and compared within 
measures. For glucagon we achieved CVs of 5.9% (Plate 1) and 14.2% (Plate 2), for an 
inter-plate CV of 10.1%. For leptin we achieved CVs of 4.7% (Plate 1) and 4.3% (Plate 
2), for an inter-plate CV of 4.5%. For insulin we achieved CVs of 2.0% (Plate 1) and 
8.5% (Plate 2), for an inter-plate CV of 5.3%. For glucose we achieved CVs of 3.8% 
(Plate 1) and 1.0% (Plate 2), for an inter-plate CV of 2.4%.  
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Table 6. Influence of beverage type and intake timing on change in fasting serum 
metabolic markers. 
Marker  
Dairy  CHO  
Immediate (n=7) Alternate (n=5) Immediate (n=7) Alternate (n=4) 
Leptin (ng/ml) 0.50 ± 0.85 0.08 ± 2.00 -1.92 ± 1.86 1.10 ± 1.07 
Glucagon (pg/ml) 1.34 ± 2.73 -19.70 ± 8.12 -0.05 ± 18.17 -4.61 ± 7.84 
Insulin (pg/ml) 20 ± 60 -81 ± 93 -94 ± 95 110 ± 101 
HOMA index 0.16 ± 0.23 -0.31 ± 0.40 -0.32 ± 0.36 -0.69 ± 0.58 
DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 4. No significant differences between 
groups or time points. Trend toward significance for HOMA index to be lower post-
intervention (p < 0.08).  
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9. Discussion  
The primary purpose of this study was to determine the combined effects of increased 
physical activity and dairy consumption on body composition, VO2peak, blood lipids and 
metabolic markers. The main hypothesis was that combining increased LFM intake with 
endurance exercise training would augment the physiological and health-related 
adaptations that would be experienced with training alone; however, the majority of 
findings of this study do not support this hypothesis. Also, the hypothesis that all groups 
would experience an increase in VO2peak was not fully supported. All experimental 
groups did exhibit a significant increase in relative VO2peak which was similar between 
the different groups (Time 1: 41.6ml/min/kg; Time 2: 44.2ml/min/kg; p < 0.05). Despite 
the increases in relative VO2peak, there were no significant differences in absolute 
VO2peak values, although the changes from baseline exhibit a notable trend (p = 0.07). 
Furthermore, the hypothesis that combining training and LFM intake would reduce whole 
body inflammation and inflammatory markers was also not supported, as there were no 
significant differences between experimental groups or time points for any inflammatory 
or anti-inflammatory markers. The combination of endurance training and LFM also did 
not appear to have any effects on fasting serum cholesterol levels, glucose or insulin. 
9.1 Vitamin D – intake and serum levels 
A surprising finding in this study was that vitamin D (25-(OH) D3) status did not 
change significantly from baseline in any of the groups that consumed LFM. Due to 
fortification of milk with vitamin D2 in Canada, we had expected to see an increase or at 
least maintenance of serum-vitamin D status. It is possible that our observations were due 
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to a number of different reasons.  Firstly, seasonal variations in exposure to ultraviolet 
radiation may have contributed to variability in results, as the majority of our participants 
completed the study during the fall and winter months.  Furthermore, participants were 
not taking any other supplements, and as such feeding them 3 servings of low fat milk 
does not appear to be adequate to maintain serum 25-(OH)D levels. Finally, there is some 
evidence to suggest that it may take at least 3 months of increased vitamin D intake to see 
notable changes in serum vitamin D levels [106], and we may have seen no changes with 
our intervention as it was just barely at the 3-month mark. While 25-(OH)D (a.k.a 
calcidiol) is not the biologically active form of vitamin D, it does indicate the amount 
available for transition to the biologically active form, 1,25-(OH)D (a.k.a calcitriol).  
Interestingly, calcitriol uptake has been shown to be supressed by calcium ingestion. 
Zemel et al. saw significant decreases in calcitriol concentrations with dairy 
supplementation [37].  However, Caron-Jobin et al. found that women who ingested more 
than 2 servings of dairy per day had higher serum-25(OH)D than their peers ingesting 
less than 2 servings per day [13]. In addition, they found that the season/time of year of 
data collection did not affect the relationship between vitamin D and any other 
anthropometric measures [13].  It should also be noted that there is some controversy as 
to the most effective method for assessment of serum vitamin D. Our analysis employed 
the use of ELISA kits, whereas other studies have used radioimmunoassay [13, 37] or 
high pressure liquid chromatography [107, 108]. It is possible that the method employed 
in this study underestimated the levels of serum vitamin D, as the results given by the 
ELISA were at the low end of the reference interval for males 18 years or older, and all of 
the group averages were well below the population averages for overweight individuals 
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and individuals not consuming 1 serving of milk per day [109]. However, we see from 
the CV values that both our intra- and inter-assay CV values are quite low (intra-assay: 
3.6%, 6.2%; inter-assay: 4.9%) and so while our results may be low, they are reliable 
based on these values.  
9.2 Body composition 
 One of the primary expected outcomes of this study was to see a positive shift in 
body composition. We expected to see a shift in the fat-mass to lean-mass ratio, such that 
participants would decrease fat-mass and overall body-weight. While we did not observe 
any difference in body weight or fat mass change, there was a significant increase in lean 
mass as a result of the intervention. There are a few factors that may have affected these 
results, such as the addition of 3 servings of LFM, with the many potential bioactive 
components that milk contains including calcium, and daily endurance exercise. 
9.2.1 Calcium/dairy intake, and exercise for body composition 
As previously stated, we did not observe any differences between groups or time-
points for body weight or fat mass. Additionally, we did not observe any significant 
differences in calcium intake between the groups at baseline, but when the added dairy 
intake was taken into account in the DEI and DEA groups, these groups exhibited 
significantly higher calcium intakes compared to baseline and the CEI and CEA groups.  
Caron-Jobin et al. also found that individuals ingesting 2 or more servings of dairy per 
day had increased calcium intake and that this increased intake was significantly related 
to smaller visceral fat deposits compared to lower dairy and calcium intake [13].  Other 
studies have looked at milk intake as a whole food, rather than isolating the intake of 
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calcium, and investigated changes in body weight.  Barba et al. noted that children who 
ingested 2 or more servings of dairy per day had lower body weight than their peers [12]. 
Again, this is somewhat in contrast to our findings, as there were no significant 
differences between our groups with the ingestion of 3 additional servings of dairy daily 
and therefore additional calcium. These discrepancies in findings may be related to the 
duration of dairy intake – both Barba et al. and Caron-Jobin et al. employed a cross-
sectional study design to investigate individuals’ habitual dairy intake over the course of 
many years, and compared them to those who had low habitual dairy intakes over the 
same period of time [12, 13].  Based on these observations, it is possible that a longer 
duration of increased dairy intake in the current study may have resulted in similar 
findings to these two previously reported studies. However, Harvey-Berino et al. did not 
see any differences in body weight or fat mass change between groups consuming two or 
three servings of dairy per day compared to those consuming less than 2 servings per day 
over the course of 12 months, even with daily exercise of ~200 kcal expenditure [56]. 
Based on these observations, it appears that habitually elevated intake of dairy over the 
course of years, not just months, may be required in order to provide body composition 
benefits with endurance training. However, when considering dairy intake and resistance 
exercise training, a relatively short period of training and intake has been shown to result 
in fat mass loss, lean mass gain, and overall improvement in body composition [77, 97-
100].  It should be noted that the participant populations in the current study was one with 
elevated BMI and a wide age range, while the previous studies investigating the 
combined effects of dairy and resistance training recruited healthy young university aged 
individuals. 
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It was somewhat surprising that the exercise component of this intervention alone, 
without dairy intake, did not result in any significant reductions in body mass or fat mass. 
However, Hulver et al. also found no changes in body mass or fat mass in sedentary, 
overweight participants after a 6-month low-intensity endurance-training program [110].  
Similarly, Stuart et al. observed that a 8-week progressive cycling protocol elicited no 
changes in lean or fat mass for sedentary participants [111].  In contrast, Kraus et al. saw 
a significant decrease in body weight in sedentary, overweight participants with a 6-
month moderate-intensity endurance-training program [51]. It is possible based on these 
various observations that the intensity of training is a critical factor and likely contributes 
to the variability in the results in these different studies. It is important to note that 
although the studies with similar populations and exercise interventions to our study did 
not see fat mass change they did note other health benefits, in particular insulin action 
and sensitivity improvements. These results indicate that the health benefits of exercise 
are not necessarily weight-dependent.  
9.2.2 Lean mass gain 
Interestingly, we did observe the expected increase in lean mass.  Most studies that 
that have investigated the effects of endurance training have only report changes in body 
weight and fat mass, rather than lean mass, and these studies recruit both sedentary and 
recreationally active participants [51, 61, 110]. However, a resistance training study that 
included supplementation with the milk proteins casein and whey in one of the 
experimental groups, observed the greatest increases in lean mass and fat-free mass in the 
casein and whey group as compared to the control and carbohydrate supplemented groups 
[112]; it should be noted that the participants involved in this study were already 
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resistance-trained. The increase in lean mass observed in the current study was consistent 
across all of our groups, and thus cannot be attributed to the additional intake of LFM.  It 
appears that the exercise protocol itself led to the increase in lean mass in the current 
study, despite the differing results observed by Stuart et al. and the similar training 
protocol that was used [111].  In addition, our number of participants and participants 
BMI’s were similar to those involved in the study by Stuart et al.  (Stuart et al.: N = 18, 
BMI = 28-35; this study: N = 22, BMI = 23-35) [111]. 
9.3 VO2peak 
The training protocol used in the current study did lead to a significant increase in 
relative VO2peak across all groups following training; however, this finding did not 
carried over to measures of absolute VO2peak or VO2peak relative to lean mass. 
Similarly, Carter et al. found that a 7-week cycling protocol resulted in significant 
relative VO2peak improvements in both men and women [61], and Stuart et al. found the 
same with an 8-week cycling protocol in sedentary and overweight participants [111]. 
Neither the study by Carter et al. nor the one by Stuart et al. included beverage 
supplementation. Therefore, while we cannot attribute any of the VO2peak improvements 
to the beverage type, it is clear from our results and the results of other endurance training 
studies that cycling, even at low intensities, is beneficial for improving exercise capacity, 
as measured by relative VO2peak.  
9.4 Blood lipid status 
It was hypothesized that both the endurance training and the increased LFM intake 
would lead to improved blood lipid status in our participants. However, the results 
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indicated that neither endurance exercise nor beverage type had any significant post-
training effects on blood lipids. Interestingly, Zemel et al. did not find any effect of an 
additional 3 servings of low fat milk intake, over the course of 28 days, on total 
cholesterol, HDL cholesterol or triglyceride levels in overweight and obese adults [37], 
supporting our observations. In contrast, Lorenzen et al. found that high dairy calcium, 
ingested as 3 servings of milk per day as well as supplementation over 10 days, offset the 
negative effects of dairy fat to result in overall attenuation of total cholesterol and LDL 
production [55].  In addition, Caron-Jobin et al. found that women with higher calcium 
and vitamin D intakes, due to habitual ingestion of 2 or more servings of dairy per day, 
had lower triglyceride levels and lower total cholesterol concentration [13]. Steinmetz et 
al. saw a trend for lower total cholesterol, LDL, triglycerides and even HDL with 6 weeks 
of increased skim milk consumption (approximately 2 servings per day) in college-aged 
recreationally active men [60] . Ditscheid et al. also found that increased calcium reduced 
total cholesterol and LDL levels over the course of 4 weeks in young, healthy adults; 
however, calcium was not dairy-based in their experimental trials [53]. Collectively, 
these various studies indicate that dairy and calcium ingestion may lead to improvements 
in cholesterol status. The contrast in findings between these studies and ours is likely due 
to two factors: how much calcium was ingested daily and when the dairy and/or calcium 
were ingested. Two of the studies that found increased calcium supplementation 
improved blood-lipid status were using ingestion levels of 1060mg per day [53] and 
nearly 2000mg per day [55] whereas our participants were ingesting approximately 
900mg of calcium per day. It has been shown that calcium acts within the intestines to 
bind with fat, creating indigestible soaps which in turn leads to increase fat excretion and 
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improvements in blood-lipid status [19, 70]. However, in order for this interaction to 
occur, calcium must be ingested at approximately the same time as the fat. Each of the 
studies by Ditscheid et al., Lorenzen et al., and Steinmetz et al. involved dietary 
interventions which required their participants to ingest the dairy and/or calcium at the 
same time as their regular meals [53, 55, 60]. In contrast, our participants in the DEI 
group were ingesting their dairy beverage at a time when no other food was ingested, and 
although we cannot comment with confidence about the circumstances in which the DEA 
beverages were ingested, it is unlikely that other food was taken at the same time as 6 
hours post-intervention often took the participants into the late evening/early morning 
hours. Furthermore, there were no significant changes in participant reported dietary fat 
intake post-training, indicating that the lack of serum-lipid improvement was likely not 
related to increased fat ingestion offsetting any dairy-related benefits. 
Considering the effects of exercise, Kraus et al. did not see any change in total 
cholesterol or LDL for sedentary, overweight participants after a 6-month moderate-
intensity endurance-training program [51], similar to what was used in the current study. 
Interestingly, changes in blood lipids have been observed in overweight and obese 
individuals with higher training intensities – about 2 miles per day at 75% VO2peak - 
over the course of 6 months [51]. Therefore, it is possible that changes in blood lipids 
may occur with a longer period of lower intensity training, or at higher exercise 
intensities. It is possible that our intervention of 12-weeks of low-intensity cycling 
needed to be augmented in order to see changes in blood-lipids. We may have seen the 
expected changes with either higher exercise intensity or longer study duration at the 
given intensity. An increase in duration is the more likely solution as increasing the 
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intensity of training may be more problematic, due to many of the participants who were 
not accustomed to exercise, and dropped out of the current protocol because they found 
the training challenging, despite the low intensity level.  
9.5 Inflammatory and anti-inflammatory markers 
This study focussed on three markers of inflammatory status, CRP, TNF-α and IL-6, 
and one anti-inflammatory marker, adiponectin. Of the inflammatory markers measured, 
only CRP and TNF-α could be analyzed as IL-6 levels were below the level of detection 
of the Magpix® system at both baseline and post-testing. While we were able to reliably 
measure CRP and TNF-α, there were no significant differences in the resting values of 
either of these markers between groups or over time. As previously stated, the mean 
values observed for these adipokines were well within the reference ranges both at 
baseline and after the intervention (CRP reference range: <10mg/L; TNF-α: 0.0–
32.5pg/ml), indicating that our results are valid as well as reliable. Surprisingly, the anti-
inflammatory marker adiponectin significantly decreased post-intervention compared to 
baseline (p < 0.05). These results would indicate no change in inflammatory status, or 
perhaps a slight increase in inflammation as adipose-related inflammation has been 
shown in conjunction with lower adiponectin levels [7, 35, 39, 46]. However, it is 
unlikely that the decrease in adiponectin indicates increased inflammation, as at both 
baseline and post-intervention mean adiponectin values were above the healthy reference 
range of 3.7-5.7μg/ml, even with the post-intervention level decrease. One possible 
explanation is that the observed decrease was due to improved signalling and efficacy of 
adiponectin within the body – as the participants become more receptive to the effects of 
adiponectin, less is secreted and necessary to achieve the same effect [113].  
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9.5.1 Dairy intake and inflammation 
We did not observe any changes in the pro-inflammatory adipokines TNF-α or CRP, 
and we observed a significant decrease in the anti-inflammatory adipokine adiponectin. 
In contrast to our findings, Zemel et al. found that dairy consumption (3 servings per day, 
non-fat milk and/or yoghurt, for 6 months [36] and 1 month [37]) resulted in significant 
reductions of CRP, TNF-α and IL-6, as well as significant increases in adiponectin, 
indicating an overall reduction in whole-body inflammation [36, 37]. Similarly, a 1-year 
longitudinal study by Nui et al. found a significant correlation between high levels of 
low-fat dairy intake (≥2 servings per day) and high blood-adiponectin levels [114]. It is 
possible that the results of this study were different from the above studies due to our 
population – while the participants conformed to the inclusion criteria for ‘overweight’, 
many of those who completed the protocol were not as ‘unfit’ at the beginning of the 
study as desired. It should be noted that in the studies by Nui et al. [114] and Zemel et al. 
[36, 37] adiponectin was measured using ELISAs, whereas we used different 
methodologies (Milliplex®), possibly contributing to some of the differences observed. 
Furthermore, whole-body inflammation in our participants was not elevated from the 
outset, as evidenced by the non-detection of IL-6 as well as TNF-α and CRP levels falling 
within the normal reference ranges. Bearing this in mind, it is possible that we did not see 
any significant changes in inflammatory and anti-inflammatory markers due to these 
markers being low at baseline.  
9.5.2 Exercise and inflammation 
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Regarding the effects of exercise, we did not observe changes in our markers to 
indicate an improvement in inflammatory status. In contrast, Oh et al. found that a 
moderate-intensity 12-month exercise training program significantly reduced serum 
levels of TNF-α, IL-6 and leptin, while significantly increasing serum adiponectin levels 
[115]. This effect was even greater in participants who experienced weight loss through 
calorie restriction rather than exercise [115].  Hulver et al. found no change in 
adiponectin levels after a 6-month low-intensity endurance-training program [110]. 
Interestingly, Hulver et al. did observe that adiponectin levels were increased following 
weight loss as a result of gastric bypass surgery [110], indicating that changes in 
adiponectin levels may be directly associated with weight and/or fat loss rather than 
interventions that induce weight loss – the findings of Kriketos et al. and Oh et al. also 
support this theory [115, 116]. However, Kriketos et al. did find that 2-3 acute bouts of 
exercise did increase adiponectin levels, and the increase was sustained over the course of 
10 weeks [116]. Despite the increase, no correlation between weight loss, fat oxidation or 
insulin sensitivity was noted in this trial [116]. In agreement with our findings, Bruce et 
al. noted a reduction in adiponectin levels in the blood stream with 8 weeks of endurance 
exercise training in obese individuals [64]. They noted that adiponectin acts in muscle 
through a pathway to increase FA oxidation [64]; endurance exercise training also 
increases FA oxidation within muscle [61, 64]. Due to both endurance training and 
adiponectin producing this outcome, a reduction in adiponectin as a result of training may 
appear contradictory. It is possible that habitual endurance exercise cancels out the 
‘redundant’ effect of adiponectin in this case, and leads to a decrease in the circulating 
concentrations of adiponectin. Another possible contributing factor as to why we did not 
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see any positive changes in adiponectin in the current study was that no changes in body 
mass were observed despite the 12 weeks of training.  Clearly, further work is required to 
better understand the relationship between diet, training, body weight/composition and 
circulating concentrations of adiponectin.  
9.6 Metabolic markers 
There were no changes or differences between groups or time points for the metabolic 
markers: fasting serum glucose, fasting serum insulin, or fasting leptin levels in this 
study.  
9.6.1 Fasting insulin 
Our findings also found no effect of exercise or beverage on fasting insulin levels. 
However, Bruce et al. did see a reduction in fasted blood-insulin levels with eight weeks 
of endurance training alone, without dairy intake [64], which is in contrast to the current 
study. Hulver et al. also saw a significant decrease in fasted insulin levels after 
overweight participants underwent a 6-month low-intensity endurance-training program 
[110]. Tong et al. found that feeding rats increased amounts of whey protein (one of the 
primary dairy proteins) led to significantly lower fasted insulin levels as compared to a 
group consuming no whey at all; however, this result was seen with a high dietary intake 
of whey (15% of their dietary kilocalories) [117]. In comparison, our participants were 
ingesting approximately 2-3% of their dietary kilocalories as whey protein, considering 
that whey makes up approximately 20% of bovine milk [118]. In conclusion, recent 
research indicates that endurance exercise is beneficial for improving fasting insulin 
levels in overweight individuals. This study did not observe this improvement perhaps 
67 
 
due to a participant population that was more ‘fit’ than an average overweight or 
sedentary individual. Perhaps a more prolonged intervention may also have been 
necessary to see improvements in insulin status. While this study did not observe any 
changes due to milk intake, there is support from animal studies indicate that 
supplementation with whey isolate may be beneficial for insulin status.  Based on these 
different observations, it is apparent that more research in this area is required, especially 
to better understand the interaction between milk intake in humans and resting insulin 
levels. 
Together, these diet- and exercise-studies indicate that neither dairy nor endurance 
exercise appear to have any beneficial effect on blood glucose levels. In contrast, 
endurance exercise does appear to beneficially affect insulin levels, although the effect of 
milk upon insulin remains unclear.  
9.6.2 Fasting glucose and HOMA index 
The current study only looked at fasting insulin levels, and thus we are unable to 
extrapolate these results to better understand how the participants would respond to a 
post-prandial glucose load.  Perhaps if we had performed an oral glucose tolerance test 
before and after the intervention, changes in insulin responsiveness would have been 
observed.  However, in order to elaborate on the results, the fasting glucose levels for our 
participants were determined. As expected based on the literature, neither the exercise 
protocol, the beverage type, nor intake timing appeared to have any effect on fasting 
blood glucose in our participants. Lunn et al. also found that milk intake combined with 
endurance exercise training did not appear to have any effect fasting blood-glucose levels 
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[88]. Lee et al. did not find beverage type (water, CHO-drink, LFM, LFM+CHO) 
affected resting blood-glucose levels with endurance training [93]. Similarly, eight weeks 
of endurance training alone, without dairy intake, has been observed to have little to no 
effect on fasting blood-glucose [64]. This effect does not appear to be duration 
dependent, as another study had overweight adults complete a 6-month low-intensity 
endurance-training program, and no changes in fasted glucose levels were observed 
[110]. To date, results of studies involving human participants indicate that there is no 
evidence to suggest that the additional consumption of LFM, with or without exercise, 
has any effect on fasting glucose levels. 
 We used the fasting glucose values to calculate the HOMA index. Values for the 
HOMA index were then analyzed to estimate insulin resistance for individual participants 
and the different experimental groups. While there were no significant differences seen 
between groups or time points, there was a trend for the HOMA index to be lower for all 
groups post-intervention when compared to baseline (p < 0.08). Struijk et al. also did not 
observe any correlation between habitual dairy intake and insulin resistance, as measured 
by the HOMA index and they did not report any trends [119].  Interestingly, Tong et al. 
found that when Wistar rats are fed increased amounts of whey protein (one of the 
primary dairy proteins) significantly lower HOMA index values are observed [117].  As 
previously stated, the rats were fed a diet that was composed of 15% whey protein, 
whereas our participants’ diets contained 2-3% whey from the dairy beverage. Other 
studies have observed statistically significant improvements in a calculated insulin 
sensitivity index in humans with 8-weeks of cycling, although the calculation used was 
[10,000/sq.root of (fasting glucose x fasting insulin) x (mean glucose x mean insulin 
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during OGTT)] rather than the HOMA index [64]. Longer duration protocols (12 months) 
have also seen significant improvements in the HOMA index with moderate-intensity 
endurance exercise training [115].  Interestingly, despite improvements in the HOMA 
index with training in an overweight/obese population, GLUT-4 expression does not 
appear to change with 8 weeks of endurance training on a cycle ergometer [111], which 
suggests improvements in signalling may account for the improvements in the HOMA 
index within 8 weeks of training in this population.  Taking the findings of these various 
studies and our study together, there is no clear relationship between milk intake and 
measures of insulin resistance. However, there is good evidence to suggest that training 
alone likely improves markers of insulin sensitivity.  
9.7 Summary of findings 
 In summary, the results of this study support the hypothesis that 12 weeks of 
exercise endurance training results in an increase in lean mass in absence of weight loss 
(p < 0.05) – this hypothesis was supported regardless of the type or timing of beverage 
consumed by participants. Furthermore, a significant increase in relative VO2peak (p < 
0.05) coupled with a trend toward significance for absolute VO2peak increase (p = 0.07) 
was observed. Surprisingly, there was a significant main effect for the anti-inflammatory 
marker adiponectin to be lower across all groups at the end of the 12-week exercise 
intervention (p < 0.05). However, the main hypothesis that the groups consuming LFM 
would exhibit increased benefit from the exercise training was not supported. 
Furthermore, there were no changes observed in any group for the measures of serum 
cholesterol and triglycerides, serum glucose and insulin, or serum pro-inflammatory 
markers. While our measures did not allow us to speculate about how participants would 
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respond to a glycemic load as an adaptation to the training, we were able to perform a 
HOMA index calculation which indicated that all groups exhibited a reduction in this 
index post intervention (p = 0.08) which suggests that the 12-week endurance exercise 
intervention has the potential to reduce insulin resistance in a sedentary population.  
 Although the primary novel hypotheses of this study were not supported, the 
significant results indicate that this 12-week cycling intervention was effective for 
producing a training effect in a sedentary and primarily overweight population. While the 
training effect was limited to lean mass gain and VO2peak improvement, this intervention 
does have the potential for further improved adaptations.  
9.8 Implications and strengths 
 This area of research, investigating the combined interventions of dairy and 
exercise and their effects on weight management and inflammation, is important as the 
incidences of overweight and obesity are widespread and concerning.  Obesity brings 
with it risk factors for many other health problems, it is essential for healthy behavioural 
changes to be integrated into daily life to combat obesity and the associated risk factors. 
The purpose of our study was to investigate a relatively easy lifestyle strategy that can be 
readily implemented for overweight individuals. This strategy aimed to address the issue 
of weight management and also the chronic and elevated inflammation and oxidative 
stress these individuals experience. A strength of this study was that participation brought 
otherwise sedentary individuals up to recommended levels of both daily activity (30-
60min/d of light-moderate exercise at 50-65%HRmax, ~5d/wk [82, 120] and daily dairy 
intake (at least 2 servings/day) [69]. We did not observe most of the positive adaptations 
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that we had hypothesized would be observed in response to the intervention, and this may 
be partially related to the low-intensity exercise protocol that was used. However, while a 
higher intensity may have produced more physiologically significant results, it is also 
likely that our adherence rate would have been much lower, and dropout rate higher 
considering the sample population and demographic. Furthermore, considering that the 
intensity of training complied with Health Canada’s recommendations for physical 
activity, it is also possible that the duration of study was too short to elicit the adaptations 
based on the intensity used, rather than the intensity being too low. While the results 
observed may not have been expected, they do reflect an intervention that is more 
appealing and practical for this at-risk population. As such, a more prolonged 
intervention at the same intensity may be necessary to elicit the expected physiological 
benefits while being more desirable and plausible for this population. 
9.9 Limitations and Future Directions 
There were a number of limitations with the current study that warrant further 
discussion. We were unable to recruit the desired number of participants, only enrolling 
40 of the expected 56 participants. It should be noted that of the 40 who began the study, 
only 23 completed it, resulting in a significant drop-out rate of 42.3%.  Furthermore, one 
of our participants experienced pulmonary illness toward the end of the study – although 
he completed the training and testing protocols, his post-training results had to be 
excluded from statistical analysis, leaving a final n = 22. This necessary exclusion was 
especially disappointing considering that his individual post-test results, taken during his 
illness, were comparable to his healthy pre-test results, indicating that a healthy post-test 
would have resulted in improvement. Based on this n, power calculations were performed 
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using an alpha of 0.05 and effect sizes of the main outcomes (ranging from 0.02-0.3) 
which resulted in a final power of less than 0.01. An a priori power analysis was also 
performed to determine the required sample size to give a power of 0.8 based on the 
obtained data, and these indicated that the current study would need a minimum of 238 
participants. This would suggest that the current sample was insufficient to elicit the 
expected outcomes.  
Based on informal interviews and discussion with the participants, the significant 
drop-out rate was related to two issues: the location of daily training and the 12- week 
training time period. Due to space constraints on the main Brock campus, the training 
took place at the Brock Research and Innovation Centre, which was not easily accessible 
for participants who did not have access to a vehicle. Furthermore, the 12-weeks of 
training had to be split up over two semesters. The change in semesters brought its own 
set of challenges: class schedules that permitted regular training during the fall semester 
were not so flexible during the winter semester, and seasonal weather changes made 
travel to and from the Centre even more difficult and inconvenient. Participants who did 
not drop out altogether for these reasons missed many days that had to be made up later, 
pushing the ‘end date’ of the study over a month longer than anticipated. Furthermore, 
the researchers had no feasible method other than the ‘honour code’ to ensure that 
participants were following the guidelines of the study outside of their hour of training. 
For example, there was no method of ensuring the DEA and CEA groups consumed their 
beverage at the appropriate time, or at all, and there was no way to ensure that other 
lifestyle changes – such as eating habits or intermural sports – were not changed or added 
to participant routines during the course of the study.  
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Considering the outcomes of this study, it is difficult to say where to go next as 
these results are inconclusive. However, as this area of research has the potential for 
beneficial results, especially for the overweight/inactive population, it would be valuable 
to repeat this study or to run another training cohort to improve participant numbers and 
statistical power. If this study is to be repeated with university students, shorter study 
duration for improved adherence over the course of one semester may be necessary. On 
the other hand, longer study duration may be necessary to see adaptations in this 
population at this intensity of exercise, so perhaps a population with a consistent schedule 
should be considered for recruitment of participants. A similar study may investigate 
post-prandial glucose and insulin responses alongside fasted measures. In order to better 
determine changes in inflammatory markers, it may be beneficial to repeat this protocol 
with participants who suffer from dyslipidemia as well as being overweight. Furthermore, 
including muscle tissue sampling and analysis would be important for looking directly at 
oxidative stress markers and antioxidant levels. This would allow for investigation into 
how the intervention is affecting this health issue, as the current methodology only allows 
assumptions to be made through inflammatory marker results. 
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10. Conclusion 
In summary, the findings of this study do not support the original hypotheses. Based 
on the current observations, there appears to be no added benefit of milk consumption 
coupled with 12 weeks of exercise training in comparison to 12 weeks of exercise 
training alone or a carbohydrate beverage coupled with 12 weeks of exercise, on 
measures of fat and lean mass, changes in blood lipids, metabolic markers, or whole body 
inflammation. There were no significant changes in body mass or fat mass, although 
interestingly lean mass did increase significantly from baseline in all groups, as did 
exercise capacity, as measured by relative VO2peak. There were no significant changes in 
markers of inflammation due to increased dairy intake and increased endurance training, 
and there were no significant changes in blood lipid or metabolic markers. Furthermore, 
timing of beverage consumption did not appear to have any significance for augmenting 
adaptations due to training over the course of 12 weeks.  Therefore, based on the current 
study, there does not appear to be added benefits to combining increased low-fat dairy 
intake with moderate intensity endurance exercise for 12 weeks in a population at risk for 
become obese.   
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12. Appendix 
12.1 Pre- and post-testing data 
12.1.1 Nutritional intake 
Table A1. Total energy and macronutrient intake by group and time point 
Dietary Intake 
per day 
DEI  DEA  CEI  CEA  
Pre Post Pre Post Pre Post Pre Post 
Kcal 
2845 ± 
424 
1931 ± 
337 
2215 ± 
297 
2622 ± 
245 
2373 ± 
225 
2148 ± 
531 
2641 ± 
395 
2165 ± 
153 
CHO (Kcal) 
1500 ± 
224 
945 ± 
171 
878 ± 
181 
1354 ± 
110 
1089 ± 
138 
1162 ± 
233 
1029 ± 
104 
1028 ± 
164 
CHO (g) 310 ± 56 236 ± 43 220 ± 45 339 ± 28 272 ± 35 291 ± 58 257 ± 26 257 ± 41 
PRO (Kcal) 423 ± 75 303 ± 51 357 ± 57 407 ± 75 
518 ± 
105 
418 ± 51 457 ± 39 384 ± 46 
PRO (g) 106 ± 19 76 ± 13 89 ± 14 102 ± 19 129 ± 26 105 ± 13 114 ± 10 96 ± 11 
FAT (Kcal) 
830 ± 
102 
688 ± 
132 
820 ± 
212 
900 ± 
147 
857 ± 92 
858 ± 
153 
1170 ± 
356 
722 ± 17 
FAT (g) 92 ± 11 76 ± 15 91 ± 24 100 ± 16 95 ± 10 95.± 17 130 ± 40 80 ± 2 
Abbreviations: DEI – Dairy-Exercise-Immediate group; DEA – Dairy-Exercise-Alternate 
group; CEI – Carbohydrate-Exercise-Immediate group; CEA – Carbohydrate-Exercise-
Alternate group; Kcal: kilocalorie; CHO: carbohydrate intake; PRO: protein intake; FAT: 
fat intake; g - grams. DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 4. No significant 
differences between groups or time-points. 
  
84 
 
12.1.2 Serum vitamin D  
 
Figure A1. Vitamin D status by group and time point. 
Abbreviations: DEI – Dairy-Exercise-Immediate; DEA – Dairy-Exercise-Alternate; CEI 
– Carbohydrate-Exercise-Immediate; CEA – Carbohydrate-Exercise-Alternate. DEI: n = 
7. DEA: n = 5. CEI: n = 6. CEA: n = 4. No significant differences between groups or time 
points.   
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12.1.3 Body composition 
Table A2. Body composition measures by group and time point. 
 
DEI  DEA  CEI  CEA  
Pre Post Pre Post Pre Post Pre Post 
Body mass 
(kg) 
80 ± 4 80 ± 3 83 ± 6 84 ± 5 91 ± 6 91 ± 6 86 ± 4 87 ± 3 
Fat mass (kg) 20 ± 2 21 ± 1 23 ± 4 23 ± 4 28 ± 3 27 ± 1 25 ± 2 26 ± 2 
Lean mass 
(kg) 
56 ± 2 57 ± 2* 57 ± 1 58 ± 1* 63 ± 4 64 ± 4* 59 ± 3 60 ± 4* 
Abbreviations: DEI – Dairy-Exercise-Immediate group; DEA – Dairy-Exercise-Alternate 
group; CEI – Carbohydrate-Exercise-Immediate group; CEA – Carbohydrate-Exercise-
Alternate group; kg: kilogram. DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 4. *Increase 
of lean mass across all groups from baseline (p < 0.05). 
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12.1.4 VO2peak 
Table A3. VO2peak measures by group and time point. 
VO2peak 
DEI  DEA  CEI  CEA  
Pre Post Pre Post Pre Post Pre Post 
Absolute 
(L/min) 
3.7 ± 0.2 
4.0 ± 
0.1^ 
3.3 ± 0.2 
3.2 ± 
0.3^ 
3.9 ± 0.4 
4.3 ± 
0.4^ 
3.1 ± 0.4 
3.3 ± 
0.4^ 
Relative 
(ml/kg/min) 
46.9 ± 
1.2 
51.8 ± 
3.2* 
40.5 ± 
5.0 
41.9 ± 
5.3* 
43.8 ± 
3.1 
47.7 ± 
3.0* 
35.3 ± 
4.0 
37.6 ± 
3.3* 
Relative to LM 
(ml/kg LM/min) 
66.7 ± 
2.9 
66.9 ± 
1.0 
57.1 ± 
5.0 
57.5 ± 
5.9 
64.0 ± 
2.8 
69.4 ± 
2.9 
52.3 ± 
5.7 
55.1 ± 
5.7 
Abbreviations: DEI – Dairy-Exercise-Immediate group; DEA – Dairy-Exercise-Alternate 
group; CEI – Carbohydrate-Exercise-Immediate group; CEA – Carbohydrate-Exercise-
Alternate group; L/min: litres per minute; ml/kg/min: millilitres per kilogram per minute; 
LM: lean mass; ml/kg LM/min: millilitres per kilogram of lean mass per minute. DEI: n = 
7. DEA: n = 5. CEI: n = 6. CEA: n = 4. ^Trend toward significance for absolute VO2peak 
to be higher compared to baseline (p < 0.07). *Increase in relative VO2peak values from 
baseline (p < 0.05).  
 
 
  
87 
 
12.1.5 Serum lipids 
 
Figure A2. Total cholesterol by group and time point.  
Abbreviations: DEI – Dairy-Exercise-Immediate; DEA – Dairy-Exercise-Alternate; CEI 
– Carbohydrate-Exercise-Immediate; CEA – Carbohydrate-Exercise-Alternate. DEI: n = 
7. DEA: n = 5. CEI: n = 6. CEA: n = 4. *TCHOL was significantly lower overall for DEI 
and CEI groups in comparison to DEI and DEA groups (p < 0.05); this effect is not 
attributable to the intervention. 
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Table A4. Serum lipids by group and time point 
Marker 
(mmol/L) 
DEI  DEA  CEI  CEA  
Pre Post Pre Post Pre Post Pre Post 
TCHOL 4.3 ± 0.3* 4.3 ± 0.3* 4.7 ± 0.3 4.7 ± 0.2 4.2 ± 0.3* 4.3 ± 0.3* 5.6 ± 0.6 5.5 ± 0.6 
LDL 2.6 ± 0.3* 2.6 ± 0.2* 2.9 ± 0.3 2.9 ± 0.3 2.5 ± 0.2* 2.6 ± 0.3* 3.5 ± 0.5 3.6 ± 0.6 
TGs 1.8 ± 0.4 1.5 ± 0.2 1.1 ± 0.2 0.9 ± 0.1 1.1 ± 0.2 1.0 ± 0.1 2.0 ± 0.4 2.4 ± 0.9 
HDL 1.1 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 
Abbreviations: TCHOL: Total cholesterol; LDL: Low-density lipoprotein cholesterol; 
TGs: Triglycerides; HDL: High-density lipoprotein cholesterol; DEI – Dairy-Exercise-
Immediate; DEA – Dairy-Exercise-Alternate; CEI – Carbohydrate-Exercise-Immediate; 
CEA – Carbohydrate-Exercise-Alternate. DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 
4. *TCHOL and LDL values were significantly lower overall for DEI and CEI groups in 
comparison to DEA and CEA groups (p < 0.05); this finding is not attributable to the 
intervention. No other significant effects noted.  
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12.1.6 Inflammatory and anti-inflammatory markers 
 
Figure A3. TNF-α (A), CRP (B) and adiponectin (C) by group and time point. 
Abbreviations: TNF-α – Tumour necrosis factor alpha; CRP – C-reactive protein; DEI – 
Dairy-Exercise-Immediate; DEA – Dairy-Exercise-Alternate; CEI – Carbohydrate-
Exercise-Immediate; CEA – Carbohydrate-Exercise-Alternate. DEI: n = 7. DEA: n = 5. 
CEI: n = 6. CEA: n = 4. *All groups showed a decrease in adiponectin levels compared to 
baseline (p < 0.05).   
90 
 
Table A5. Fasting inflammatory markers by group and time point 
 DEI DEA CEI CEA 
Marker Pre Post Pre Post Pre Post Pre Post 
TNFα 
(pg/ml) 
4.3 ± 0.9 3.6 ± 0.6 3.6 ± 0.3 3.5 ± 0.2 3.5 ± 0.5 3.6 ± 0.7 3.5 ± 0.5 3.7 ± 0.5 
CRP 
(ng/ml) 
1.8 ± 0.8 0.9 ± 0.2 1.9 ± 0.7 1.9 ± 0.8 2.9 ± 0.8 2.4 ± 0.7 1.5 ± 0.4 1.1 ± 0.2 
Adiponectin 
(μg/ml) 
10.0 ± 
2.0 
7.9 ± 1.4* 
11.8 ± 
2.1 
9.6 ± 2.4* 
12.0 ± 
1.6 
10.1 ± 
2.7* 
7.2 ± 1.9 6.6 ± 1.8* 
Abbreviations: TNF-α – Tumour necrosis factor alpha; pg/ml – picograms per millilitre; 
CRP – C-reactive protein; ng/ml – nanograms per millilitre; μg/ml – micrograms per 
millilitre; DEI – Dairy-Exercise-Immediate; DEA – Dairy-Exercise-Alternate; CEI – 
Carbohydrate-Exercise-Immediate; CEA – Carbohydrate-Exercise-Alternate. DEI: n = 7. 
DEA: n = 5. CEI: n = 6. CEA: n = 4. *All groups showed a decrease in adiponectin levels 
compared to baseline (p < 0.05). 
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12.1.7 Metabolic markers 
Table A6.  Fasting serum metabolic markers by group and time point  
 DEI DEA CEI CEA 
Marker Pre Post Pre Post Pre Post Pre Post 
Glucose  
(mmol/l) 
3.1 ± 0.1 3.2 ± 0.1 3.2 ± 0.1 3.2 ± 0.1 3.2 ± 0.1 3.2 ± 0.1 3.7 ± 0.4 3.3 ± 0.1 
Leptin  
(ng/ml) 
6.1 ± 1.8 6.6 ± 2.2 8.4 ± 3.0 6.9 ± 2.2 8.8 ± 1.8 6.9 ± 1.9 6.9 ± 2.3 8.0 ± 2.3 
Glucagon 
(pg/ml) 
49 ± 8 50 ± 8 77 ± 15 53 ± 12 57 ± 20 57 ± 9 52 ± 10 47 ± 10 
Insulin  
(pg/ml) 
529 ± 96 
549 ± 
112 
522 ± 
137 
385 ± 79 
424 ± 
114 
329 ± 64 446 ± 66 
556 ± 
143 
HOMA 
index * 
2.1 ± 0.4 2.3 ± 0.5 2.0 ± 0.5 1.7 ± 0.3 1.7 ± 0.5 1.4 ± 0.3 2.1 ± 0.3 1.4 ± 0.3 
Abbreviations: HOMA – Homeostatic Model Assessment; DEI – Dairy-Exercise-
Immediate; DEA – Dairy-Exercise-Alternate; CEI – Carbohydrate-Exercise-Immediate; 
CEA – Carbohydrate-Exercise-Alternate. DEI: n = 7. DEA: n = 5. CEI: n = 6. CEA: n = 
4. No significant differences between groups or time points. *Trend toward significance 
for HOMA index to be lower post-intervention (p < 0.08).  
  
